id,slug,category_id,sequence,synonyms,overview,mechanism_of_action,two_d_structure_photo,iupac_name,molecular_mass,potential_research_fields,citations,chemical_formula,name,created_at,updated_at,category_name,color_bg,color_text,icon,created_at_category,updated_at_category
2,tb-500,3.0,Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH,"Thymosin Beta-4, TB4","TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide that plays a crucial role in wound healing, tissue repair, and cellular regeneration. It is produced by the thymus gland and found in high concentrations in platelets, macrophages, and other cells involved in tissue repair.","TB-500 works by binding to actin, a protein that forms the structural framework of cells. This binding promotes cell migration, angiogenesis (formation of new blood vessels), and tissue regeneration. It also has anti-inflammatory properties and can reduce scar tissue formation.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/4006ad4a-280e-4b13-f4c5-de5775c4e000/public,N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-glutamyl-L-threonyl-L-glutaminamide,889.01 g/mol,"Wound healing, tissue repair, cardiovascular health, muscle recovery, anti-aging, neuroprotection","https://pubmed.ncbi.nlm.nih.gov/22074294/, https://pubmed.ncbi.nlm.nih.gov/23050815/, https://pubmed.ncbi.nlm.nih.gov/17803837/",C38H68N10O14,TB-500,2025-04-15T02:28:26+00:00,2025-08-19T23:36:51+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
3,mt-2,4.0,Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2 (cyclic),"Melanotan II, MTII, MT-II",Melanotan II is a synthetic peptide hormone that stimulates melanogenesis (tanning) and has effects on sexual arousal and appetite suppression. It is an analog of the naturally occurring hormone alpha-melanocyte stimulating hormone (alpha-MSH).,"MT-2 acts as a non-selective agonist of melanocortin receptors (MC1R, MC3R, MC4R, MC5R). Activation of MC1R stimulates melanogenesis, MC4R affects sexual arousal and appetite, while MC3R and MC5R have various metabolic effects.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/c5b1813d-013b-4abc-d06d-a68a571e8900/public,"cyclo[Nle4,Asp5,D-Phe7,Lys10]alpha-MSH(4-10)amide",1024.18 g/mol,"Dermatology, sexual dysfunction, appetite regulation, metabolic disorders","https://pubmed.ncbi.nlm.nih.gov/8954023/, https://pubmed.ncbi.nlm.nih.gov/9707292/, https://pubmed.ncbi.nlm.nih.gov/11891291/",C50H69N15O9,MT-2,2025-04-15T02:28:26+00:00,2025-08-19T23:37:05+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
4,kpv,5.0,Lys-Pro-Val,"Tripeptide KPV, Lysine-Proline-Valine","KPV is a tripeptide derived from alpha-melanocyte stimulating hormone (alpha-MSH) that exhibits potent anti-inflammatory properties. Unlike its parent hormone, KPV does not cause skin pigmentation but retains the anti-inflammatory effects.","KPV exerts its anti-inflammatory effects by inhibiting NF-kB activation and reducing the production of pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6. It also modulates immune cell function and promotes tissue repair.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/69750036-dea2-4318-edc3-e71fd3710d00/public,L-lysyl-L-prolyl-L-valine,371.46 g/mol,"Inflammatory bowel disease, dermatitis, wound healing, autoimmune disorders","https://pubmed.ncbi.nlm.nih.gov/18061177/, https://pubmed.ncbi.nlm.nih.gov/15936788/, https://pubmed.ncbi.nlm.nih.gov/16390824/",C16H31N5O4,KPV,2025-04-15T02:28:26+00:00,2025-08-19T23:37:11+00:00,Anti-inflammatory,#FFF3E0,#E65100,Pill,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
18,oxytocin,13.0,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (with disulfide bond),"OT, Love hormone, Pitocin, Syntocinon","Oxytocin is a naturally occurring neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary gland. It plays crucial roles in social bonding, trust, empathy, and relationship-building, earning it the nickname love hormone.","Oxytocin binds to oxytocin receptors (OXTR) in the brain and peripheral tissues. In the brain, it modulates social behavior, stress response, and emotional regulation, appetite. Peripherally, it affects smooth muscle contraction, senescence and various physiological processes.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=439302&t=l,L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-6)-disulfide,1007.19 g/mol,"Social Behavior, Autism Spectrum Disorders, Anxiety, Depression, PTSD, Relationship Therapy, Obesity, Muscle Wasting","https://pubmed.ncbi.nlm.nih.gov/24785132/, https://pubmed.ncbi.nlm.nih.gov/23922128/, https://pubmed.ncbi.nlm.nih.gov/25136068/",C43H66N12O12S2,Oxytocin,2025-04-15T02:28:26+00:00,2025-09-29T07:53:44+00:00,Neuropeptide,#E3F2FD,#1565C0,Brain,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
19,hcg,4.0,Complex glycoprotein with alpha and beta subunits,"Human Chorionic Gonadotropin, beta-hCG, Pregnyl","Human Chorionic Gonadotropin (hCG) is a glycoprotein hormone produced during pregnancy. In therapeutic applications, it is used to stimulate testosterone production in males and support fertility treatments in both sexes.","hCG mimics luteinizing hormone (LH) by binding to LH/CG receptors. In males, it stimulates Leydig cells to produce testosterone and supports spermatogenesis. In females, it can trigger ovulation and support corpus luteum function.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/1f7feb81-23fc-4469-ee9f-c76de27d2300/public,Human chorionic gonadotropin,36700 Da,"Male hypogonadism, fertility treatment, weight management, testosterone replacement therapy","https://pubmed.ncbi.nlm.nih.gov/23870423/, https://pubmed.ncbi.nlm.nih.gov/24589384/, https://pubmed.ncbi.nlm.nih.gov/22928524/",Complex glycoprotein,HCG,2025-04-15T02:28:26+00:00,2025-08-19T23:37:18+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
20,glutathione,5.0,Glu-Cys-Gly,"GSH, L-Glutathione, Glutathione reduced","Glutathione is the master antioxidant found in every cell of the human body. This tripeptide plays a crucial role in protecting cells from oxidative stress, supporting immune function, and facilitating detoxification processes.","Glutathione neutralizes free radicals and reactive oxygen species through electron donation. It also serves as a cofactor for various enzymes involved in detoxification, supports regeneration of other antioxidants like vitamins C and E, and maintains cellular redox balance.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/6be95ccd-1a09-40ec-f59d-25e6771c3600/public,Î³-Glutamylcysteinylglycine,307.32 g/mol,"Anti-aging, detoxification, immune support, neurodegenerative diseases, liver health, skin whitening","https://pubmed.ncbi.nlm.nih.gov/21796620/, https://pubmed.ncbi.nlm.nih.gov/22336403/, https://pubmed.ncbi.nlm.nih.gov/23375458/",C10H17N3O6S,Glutathione,2025-04-15T02:28:26+00:00,2025-08-03T03:19:50+00:00,Anti-inflammatory,#FFF3E0,#E65100,Pill,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
26,cjc-1295,4.0,Modified GHRH(1-29) with drug affinity complex,"CJC-1295 with DAC, Modified GHRH, Growth hormone releasing hormone analog",CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been modified to increase its half-life and stability. The DAC (Drug Affinity Complex) version provides extended release of growth hormone.,"CJC-1295 binds to and activates GHRH receptors on somatotroph cells in the anterior pituitary, stimulating the synthesis and release of growth hormone. The DAC modification extends its half-life to approximately 6-8 days.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=56841945&t=l,Modified growth hormone releasing hormone (1-29) with maleimidopropionyl-drug affinity complex,3647.28 g/mol,"Growth hormone deficiency, anti-aging, muscle wasting, lipodystrophy, metabolic disorders","https://pubmed.ncbi.nlm.nih.gov/16352683/, https://pubmed.ncbi.nlm.nih.gov/18160750/, https://pubmed.ncbi.nlm.nih.gov/16608754/",C165H269N47O46,CJC-1295,2025-04-15T02:28:26+00:00,2025-09-29T07:40:46+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
177,fgl,13.0,H-Glu-Val-Tyr-Val-Val-Ala-Glu-Asn-Gln-Gln-Gly-Lys-Ser-Lys-Ala-OH,"HY-P3281, DA-53184, CS-0655069, NCAM-Mimetic","FGL is derived from neural cell adhesion molecule and has been extensively studied for its neurotrophic effect that include neuroprotection, cognitive enhancement, neurogenesis and neuroplasticity.","FGL improves cognition by activating the PKC pathway, and by enhancing the delivery of AMPA receptors to synapses.",,N-[(2S)-2-amino-3-phenylpropanoyl]-L-glycine,1649.8 g/mol,,,C71H116N20O25,FGL,2025-10-07T12:33:11+00:00,2025-10-07T12:35:28+00:00,Neuropeptide,#E3F2FD,#1565C0,Brain,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
21,semax,21.0,Met-Glu-His-Phe-Pro-Gly-Pro,"MEHFPGP, Semax peptide","Semax is a heptapeptide and synthetic fragment of adrenocorticotropic hormone (ACTH) that has been studied for its potential in cognition, neurogenesis, and neuroprotection. It is currently not FDA approved, though it has quite a few human trials. Semax has been studied for uses in stroke treatment, with trials using post-stroke human patients as well as pMCAO induced rodents. It has also been discussed in applications of ADHD in hypothetical mechanistic articles.

It is bioavailable in injectable form (subcutaneous, intramuscular, i.p.) and intranasally, but it is not bioavailable orally due to degradation by peptidases in the stomach/intestinal tract.","Semax has a variety of elucidated and hypothesized mechanisms. Its main mechanism seems to be its ability to increase brain-derived neurotrophic factor (BDNF), thus potentiating downstream neuroprotective and neurotropic action. 

Semax also increases the expression of several genes related to the immune and vascular systems. Particularly, those associated with are associated with processes like the development and migration of endothelial tissue, the migration of smooth muscle cells, hematopoiesis, and vasculogenesis.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/c7087a8d-dc07-468d-9ebd-120d403bdd00/public,(2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid,813.92 g/mol,"Cognitive enhancement, neuroprotection, stroke recovery, ADHD, memory improvement, anxiety","https://pubmed.ncbi.nlm.nih.gov/23132820/, https://pubmed.ncbi.nlm.nih.gov/22336658/, https://pubmed.ncbi.nlm.nih.gov/21105114/",C37H51N9O10S,Semax,2025-04-15T02:28:26+00:00,2025-09-27T16:58:40+00:00,Cognition,#E3F2FD,#1565C0,Notebook,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
22,pt-141,21.0,Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH,"Bremelanotide, BMT, Vyleesi","Bremelanotide, more commonly known as PT-141, is a cyclic heptapeptide used to promote sexual drive. It is a synthetic derivative of alpha-melanocyte stimulating hormone and an active metabolite of MT-2. It is currently FDA approved for the treatment of female hypoactive sexual desire disorder (HSSD) in the brand name Vyleesi. 

Bremelanotide is slightly pharmacologically different from MT-2, though it still possesses similar side-effects to MT-2, including nausea, flushing, and headache.","Bremelanotide works by selectively agonizing the melanocortin receptors - specifically, the melanocortin 3 and 4 receptors. These receptors are located in certain brain regions associated with sexual function. Agonism of these receptors may also downstream cause increases in dopamine, further explaining their mechanism of increasing sexual drive. It does have a weaker affinity for the MC1 and MC5 receptors, but the affinity is not considered high enough for the drug to be considered a target for these receptors.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/3c93ed55-4669-4a31-513e-5b2e7e904400/public,"(3S,6S,9R,12S,15S,23S)-15-[(N-Acetyl-L-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxylic acid",1025.182 g/mol,"Female sexual dysfunction, erectile dysfunction, libido enhancement, sexual arousal disorders","https://pubmed.ncbi.nlm.nih.gov/31006074/, https://pubmed.ncbi.nlm.nih.gov/30574800/, https://pubmed.ncbi.nlm.nih.gov/29577872/",C50H68N14O10,PT-141,2025-04-15T02:28:26+00:00,2025-10-24T23:04:41+00:00,Cognition,#E3F2FD,#1565C0,Notebook,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
23,retatrutide,19.0,YAÂ¹QGTFTSDYSILÂ²LDKKâ´AQAÂ¹AFIEYLLEGGPSSGAPPPSÂ³,"LY3437943, Triple agonist peptide","Retatrutide is a triple-hormone agonist of glucagon-related receptors developed by Eli Lilly and Company. Unlike semaglutide and tirzepatide, no research has been done on its safety in efficacy in clinically obese individuals, though it has been shown efficacious and well-tolerated in non-obese overweight individuals. In one phase 2 placebo-blind trial, retatrutide showed a dose dependant decrease in weight loss, with the 12-mg weekly group having a 22% reduction in body weight by 24 weeks.","Retatrutide promotes weight loss by agonizing three glucagon-related receptors: the glucagon-like peptide 1 (GLP-1) receptor, the gastric inhibitory peptide (GIP) receptor, and the G-coupled glucagon receptor (GCCR). By agonizing these receptors, retatrutide effectively modulates glycemic-related functions.

The agonism of the GLP-1 receptor in the paraventricular nucleus in the brain results in appetite suppression, and agonism of this receptor in the body slows gastric emptying and promotes insulin release by the pancreatic beta cells. Agonism of the GIP receptors in the pancreas also promotes insulin secretion in a glucose-dependant manner. Finally, agonism of the GCCR promotes direct lipolysis and increases BMR, as well as mobilization of triglycerides.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/48cd2bf2-7bda-4984-74bf-a05f52a84e00/public,Ugh too long ffs increase the limit,4845.444 g/mol,"Obesity, type 2 diabetes, weight management, metabolic syndrome","https://pubmed.ncbi.nlm.nih.gov/36562446/, https://pubmed.ncbi.nlm.nih.gov/37354532/, https://www.nejm.org/doi/full/10.1056/NEJMoa2301972",C223H343F3N46O70,Retatrutide,2025-04-15T02:28:26+00:00,2025-09-27T05:02:50+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
24,selank,21.0,Thr-Lys-Pro-Arg-Pro-Gly-Pro,"TKPRPGP, Selank peptide","Selank is an anxiolytic heptapeptide used for its cognitive enhancing and anxiolytic properties. It is a synthetic analogue of the endogenous immunomodulatory peptide tuftsin. In rodents, it has been shown to decrease stress, anxiety, and fear response, and increase cognition. It is currently not FDA approved, and only a few human trials have used Selank to explore its effects.","Selank has a few complex mechanisms by which it exhibits its anxiolytic effects, and is quite unique in this manner. Predominantly, it has been shown to profoundly increase the expression of brain derived neurotrophic factor (BDNF) in the rodent hippocampal area, which plays roles in neurogenesis, anxiety, and depression. By doing so, selank is somewhat able to mimic the effects of SSRIs, which depend largely on BDNF to exert their action on anxiolysis.

Selank also has been shown to inhibit the degradation of endogenous enkephalins, a family of opioid peptides in the body. This theoretically allows selank to modulate nociception. In addition to this, selank seems to modulate the GABA receptors in some significant fashion, allowing it to further exhibit its anxiolytic effects, though the exact effect it has on the GABAergic system is not elucidated. Selank may positively allosterically modulate the GABA-A receptors.

Since it is derived from the immunomodulatory peptide tuftsin, it is somewhat pharmacologically similar in the fact that it enhances immune function. However, this function is secondary to its anxiolytic properties and is not a main goal in the clinical use of selank.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=11765600&t=l,L-Threonyl-L-lysyl-L-prolyl-N~5~-(diaminomethylene)-L-ornithyl-L-prolylglycyl-L-proline,751.887 g/mol,"Anxiety disorders, depression, cognitive enhancement, ADHD, stress management, immune modulation","https://pubmed.ncbi.nlm.nih.gov/22574404/, https://pubmed.ncbi.nlm.nih.gov/19234781/, https://pubmed.ncbi.nlm.nih.gov/16447562/",C33H57N11O9,Selank,2025-04-15T02:28:26+00:00,2025-09-29T07:54:28+00:00,Cognition,#E3F2FD,#1565C0,Notebook,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
25,ipamorelin,19.0,Aib-His-D-2-Nal-D-Phe-Lys-NH2,"IPA, Growth hormone secretagogue",Ipamorelin is a synthetic growth hormone releasing peptide (GHRP) that stimulates the release of growth hormone from the pituitary gland. It is considered one of the most selective GHRPs with minimal side effects.,"Ipamorelin binds to and activates ghrelin receptors (growth hormone secretagogue receptors) in the pituitary gland, stimulating the natural release of growth hormone. Unlike other GHRPs, it does not significantly affect cortisol or prolactin levels.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/c5b1813d-013b-4abc-d06d-a68a571e8900/public,2-amino-2-methylpropanoyl-L-histidyl-D-2-naphthylalanyl-D-phenylalanyl-L-lysinamide,711.85 g/mol,"Growth Hormone Deficiency, Anti-Aging, Muscle Building, Bone Density, Sleep Quality","https://pubmed.ncbi.nlm.nih.gov/9849822/, https://pubmed.ncbi.nlm.nih.gov/11893486/, https://pubmed.ncbi.nlm.nih.gov/15056218/",C38H49N9O5,Ipamorelin,2025-04-15T02:28:26+00:00,2025-08-07T19:27:39+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
27,dsip,13.0,Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu,"Delta Sleep-Inducing Peptide, DSIP-9",Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that promotes deep sleep and regulates sleep-wake cycles. It was first discovered in the cerebral venous blood of rabbits during sleep.,"DSIP modulates sleep architecture by influencing delta wave activity in the brain. It affects various neurotransmitter systems including GABA, serotonin, and dopamine, promoting restorative sleep and potentially affecting circadian rhythms.",https://imagedelivery.net/ey2i3L8oxd4cGMILqBg6mg/c5b1813d-013b-4abc-d06d-a68a571e8900/public,L-tryptophyl-L-alanylglycylglycyl-L-aspartyl-L-alanyl-L-serylglycyl-L-glutamic acid,849.83 g/mol,"Sleep disorders, insomnia, circadian rhythm disorders, stress management, depression","https://pubmed.ncbi.nlm.nih.gov/6114851/, https://pubmed.ncbi.nlm.nih.gov/7011304/, https://pubmed.ncbi.nlm.nih.gov/7474456/",C35H48N10O15,DSIP,2025-04-15T02:28:26+00:00,2025-08-19T23:37:27+00:00,Neuropeptide,#E3F2FD,#1565C0,Brain,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
100,bpc-157,3.0,Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val,"Stable gastric pentadecapeptide, Body Protection Compound-157, PL 14736","BPC-157 is a fifteen amino acid long oligopeptide that was discovered during research on human gastric juice. It may have cytoprotective, neuroprotective, and anti-inflammatory effects, and may also accelerate tissue and organ healing.","BPC-157 upregulates VEGF (Vascular Endothelial Growth Factor) and endothelial nitric oxide synthase (eNOS) which enhances blood vessel growth, aiding in wound healing and tissue regeneration. 
It stabilizes cell membranes, reduces oxidative stress, and modulates inflammatory cytokines. Balances nitric oxide signaling by interacting with both NOS (NO synthase) and NO pathways. Downregulates TNF-alpha, IL-6, and other pro-inflammatory mediators. Stimulates fibroblast activity, collagen production, and vascularization.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=9941957&t=l,,1419.5 g/mol,"Gastroenterology, Inflammation, Immunology, Tissue Regeneration, Orthopedics, Pulmonology, Cardiovascular disease","https://journals.physiology.org/doi/pdf/10.1152/japplphysiol.00945.2010, https://www.sciencedirect.com/science/article/abs/pii/S0736026603001104, 
https://www.eurekaselect.com/article/19497, https://link.springer.com/article/10.1007/s10787-006-1531-7, https://onlinelibrary.wiley.com/doi/10.1002/jor.21107",C62H98N16O22,BPC-157,2025-08-06T20:33:07+00:00,2025-08-07T18:07:48+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
102,tesamorelin,19.0,H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gly-Ser-Asn-Gln-Gln-Gly-Glu-Ser-Ser-Leu-Arg-Ala-Arg-Lys-NH2,"Egrifta, TH9507, GHRH(1–44) analog",Tesamorelin is a synthetic form of growth-hormone-releasing hormone (GHRH).,Tesamorelin is the N-terminally modified compound based on 44 amino acids sequence of human GHRH. This modified synthetic form is more potent and stable than the natural peptide. It is also more resistant to cleavage by the dipeptidyl aminopeptidase than human GHRH. It binds to GHRH receptor stimulating GH secretion. GH then stimulates IGF-1 secretion in the liver.,https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=16137828&t=l,,5135.91 g/mol,"Growth Hormone Deficiency, Anti-Aging, Muscle Building, Bone Density, Sleep Quality","https://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2007.00008.x, https://link.springer.com/article/10.2165/00063030-200822020-00003,
https://journals.lww.com/jpbs/fulltext/2011/03020/tesamorelin__a_hope_for_art_induced_lipodystrophy.28.aspx,",C221H366N72O67S,Tesamorelin,2025-08-07T18:27:56+00:00,2025-09-29T07:57:05+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
103,ll-37,18.0,,"LL-37, Cathelicidin LL-37, hCAP18(134–170), CAMP, UNII: 123RUE4YKT, CAS Number: 1312919-56-8",LL-37 is an antimicrobial peptide that plays a crucial role in the human immune system by helping to defend against bacterial infections. It is derived from the cathelicidin antimicrobial peptide (CAMP) gene and is known for its ability to disrupt the membranes of pathogens.,"The general rule of the mechanism triggering cathelicidin action, like that of other antimicrobial peptides, involves the disintegration (damaging and puncturing) of cell membranes of organisms toward which the peptide is active. Cathelicidins rapidly destroy the lipoprotein membranes of microbes enveloped in phagosomes after fusion with lysosomes in macrophages. Therefore, LL-37 can inhibit the formation of bacterial biofilms.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=16198951&t=l,,4493.3 g/mol,"Dermatology, Immunology","https://doi.org/10.3390%2Fijms20061475, https://doi.org/10.3390%2Fijms20061475, https://doi.org/10.1086%2F596314, https://doi.org/10.5021%2Fad.2012.24.2.126, https://doi.org/10.1038%2Fnm1616",C204H345N61O54,LL-37,2025-08-07T19:43:50+00:00,2025-09-29T07:51:15+00:00,Immune Modulation,#EFEBE9,#4E342E,Stethoscope,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
104,ghk-cu,3.0,,Copper peptide,"Copper peptide GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The tripeptide has strong affinity for copper(II) and was first isolated from human plasma. It can be found also in saliva and urine. Due to it's short half-life, frequent administration yields far better results than big dosages.","GHK-Cu is a copper-binding tripeptide that promotes tissue repair and regeneration by delivering bioavailable copper to cells and modulating gene expression. It stimulates collagen and elastin production, enhances antioxidant defenses, reduces inflammation, and promotes wound healing and hair growth. By regulating hundreds of genes involved in extracellular matrix remodeling and immune response, GHK-Cu supports skin rejuvenation, reduces scarring, and improves overall tissue health.",https://upload.wikimedia.org/wikipedia/commons/thumb/f/f3/Glycyl-L-histidyl-L-lysine.svg/250px-Glycyl-L-histidyl-L-lysine.svg.png,,340.38 g/mol,"Dermatology, Physiotherapy, Kinesiology","https://doi.org/10.1155%2F2015%2F648108, https://doi.org/10.1111%2Fj.1365-3164.2007.00647.x, https://doi.org/10.1111%2Fj.1365-3164.2006.00551.x, https://doi.org/10.1111%2Fj.1532-950x.2003.00515.x, https://doi.org/10.1111%2Fj.1532-950x.2003.00515.x, https://doi.org/10.1016%2Fj.lfs.2006.09.018, https://doi.org/10.1111%2Fj.1532-950x.2003.00515.x",C14H22CuN6O4,GHK-Cu,2025-08-07T21:03:59+00:00,2025-08-08T00:20:50+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
105,dihexa,25.0,,"PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide","Dihexa is an oligopeptide drug derived from angiotensin IV. The compound has been found to potently improve cognitive function in animal models of Alzheimer's disease-like mental impairment. In an assay of neurotrophic activity, dihexa was found to be seven orders of magnitude more potent than brain-derived neurotrophic factor.","Dihexa binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met",https://upload.wikimedia.org/wikipedia/commons/thumb/4/48/Dihexa.svg/250px-Dihexa.svg.png,,504.672 g/mol,"Mental Impairment, Cognitive Decline, Neurochemistry, Neurodegenative disease","https://doi.org/10.1124%2Fjpet.111.182220, https://doi.org/10.3389%2Ffncel.2015.00003, https://doi.org/10.3233%2FJAD-142814, https://doi.org/10.1016%2Fj.stemcr.2015.04.001, https://www.sciencedaily.com/releases/2012/10/121011090653.htm",C27H44N4O5,Dihexa,2025-08-08T00:09:49+00:00,2025-08-08T00:14:29+00:00,Nootropic,#E3F2FD,#1565C0,Brain,2025-08-06T20:14:47+00:00,2025-08-06T20:14:47+00:00
106,p21,21.0,,"cyclin-dependent kinase inhibitor 1, CDK-interacting protein 1","P21 is a small tetra-peptide derived from the most active region of CNTF (ciliary neurotrophic factor), the amino acid residues 148-151.","P21 binds to and inhibits Cyclin E/CDK2, Cyclin D/CDK4 and CDK6, Cyclin A/CDK2. This inhibition prevents phosphorylation of the retinoblastoma protein (Rb), halting the cell cycle at the G1 phase. G1 arrest allows the cell time to repair DNA damage before continuing to replicate. P21 is reported to slow the progression of neurodegeneration and Alzheimer’s by removing Tau protein build-up and reducing the production of Beta Amyloid plaques.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=56599151&t=l,,578.3 g/mol,"Cancer, Anti-Aging, Senescence, Cognitive Decline.","https://doi.org/10.1158%2F0008-5472.CAN-04-3995, https://doi.org/10.1016%2F0092-8674%2895%2990039-x, https://doi.org/10.1038%2Fnrc2657, https://doi.org/10.1128%2Fmcb.16.9.4673, https://doi.org/10.1016%2Fj.cell.2013.08.062, https://doi.org/10.1073%2Fpnas.1409797111",C30H54N65,P21,2025-08-08T00:54:52+00:00,2025-09-15T11:18:51+00:00,Cognition,#E3F2FD,#1565C0,Notebook,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
107,ara-290,18.0,Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH₂,"PHBSP, pHBSP peptide, Pyroglutamate helix B surface peptide, Cibinetide","Ara-290 is a synthetic peptide derived from erythropoietin (EPO), specifically from the B-helix region of the EPO molecule. It was engineered to retain tissue-protective and anti-inflammatory properties without stimulating erythropoiesis (red blood cell production), which is a key function of full-length EPO.","Ara-290 does not activate the classical erythropoietic receptor (EPOR-EPOR homodimer), Instead, it binds to the IRR (EPOR-CD131 heterodimer), triggering anti-inflammatory, anti-apoptotic, and pro-regenerative responses. This makes it ideal for use in tissue protection and regeneration without increasing hematocrit or causing thrombosis.",https://upload.wikimedia.org/wikipedia/commons/thumb/9/96/Cibinetide.svg/330px-Cibinetide.svg.png,,1257.324 g/mol,"Neuropathic pain, Neurology, Autoimmune disease, Chronic Inflammation, Ischemia/reperfusion injury","https://doi.org/10.1038%2Fs41419-020-2276-8, https://adisinsight.springer.com/drugs/800035038, https://synapse.patsnap.com/drug/c4639d40db674d34b3ad283c50f0cfa7",C51H84N16O21,ARA-290,2025-08-08T05:11:11+00:00,2025-09-08T00:58:40+00:00,Immune Modulation,#EFEBE9,#4E342E,Stethoscope,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
112,igf-1-lr3,4.0,,"Long arginine 3-IGF-1, LR3-IGF-1","IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the IGFBP's and has improved metabolic stability. As a result, it is approximately three times more potent than IGF-1, and possesses a significantly longer half-life of about 20–30 hours.","IGF-1 LR3 binds to the IGF-1 receptor. Once IGF-1R is activated, two primary signaling pathways are stimulated. This has effects mainly through two pathways:
1. PI3K–AKT Pathway: Promotes glucose uptake (like insulin), Inhibits apoptosis (cell death), Enhances protein synthesis and cell growth, Encourages muscle hypertrophy
2. RAS–RAF–MAPK Pathway: Stimulates cell proliferation, Promotes cell differentiation, Plays a role in tissue regeneration and repair

IGF-1 LR3 is designed to resist binding to IGFBPs, especially IGFBP-3 and IGFBP-5.
Native IGF-1 is 95% bound to IGFBPs, limiting bioavailability. The R3 substitution and 13 amino acid N-terminal extension make LR3 more bioavailable and longer-lasting in circulation.",https://pub.mdpi-res.com/biomolecules/biomolecules-11-00217/article_deploy/html/images/biomolecules-11-00217-g001.png?1612433893=,,9117.60 g/mol,"Anti-Aging, Muscle Building, Bone Density","https://doi.org/10.1677%2Fjoe.0.1500077, https://doi.org/10.1677%2Fjoe.0.1750019, https://doi.org/10.1042%2Fbj2820091, https://doi.org/10.1016%2Fj.ajpath.2010.10.007",C400H625N111O115S9,IGF-1 LR3,2025-08-13T12:30:29+00:00,2025-08-13T12:37:34+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
113,5-amino-1mq,19.0,C[N+]1=CC=CC2=C(C=CC=C12)N.[I-],"5-Amino-1-methylquinolinium, 5-Amino-1-methylquinolin-1-ium","5-Amino-1MQ is a small molecule compound known for its potential role in inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme linked to metabolic disorders, obesity, and certain cancers.","5-Amino-1MQ exerts its effects through inhibiting NNMT (nicotinamide N-methyltransferase).
NNMT regulates methylation potential in cells and influences metabolic pathways. Inhibition may: Promote fat cell metabolism, Improve energy expenditure, Reduce cancer cell proliferation.",https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/structures/156/298/6f0f92f1-873e-4f19-ad23-a69bd02a2194/640/6f0f92f1-873e-4f19-ad23-a69bd02a2194.png,5-Amino-1-methylquinolin-1-ium,159.21 g/mol,"Metabolic Disorder, Obesity, BodyBuilding, Cancer, Insulin Resistance","https://www.nature.com/articles/s41598-018-22081-7, https://pubmed.ncbi.nlm.nih.gov/29155147/, https://pubmed.ncbi.nlm.nih.gov/30753815/, https://www.nature.com/articles/s41598-018-22081-7",C10H11N2,5-Amino-1MQ,2025-08-14T22:15:22+00:00,2025-08-14T22:53:47+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
114,ss-31,20.0,D‑Arg‑Dmt‑Lys‑Phe‑NH₂,"Elamipretide, Bendavia",SS-31 is a small mitochondrially-targeted tetrapeptide that appears to reduce the production of toxic reactive oxygen species and stabilize cardiolipin.,"It localizes to the inner mitochondrial membrane and selectively binds cardiolipin. Binding to cardiolipin stabilizes it, enhancing ETC and scavenging ROS.",https://upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Elamipretide_structure.svg/250px-Elamipretide_structure.svg.png,"(2S)-6‑Amino‑2‑[[(2S)-2‑[[(2R)-2‑amino‑5‑(diaminomethylideneamino)pentanoyl]amino]‑3‑(4‑hydroxy‑2,6‑dimethylphenyl)propanoyl]amino]‑N‑[(2S)-1‑amino‑1‑oxo‑3‑phenylpropan‑2‑yl]hexanamide",639.8 g/mol,"Mitochondria, Neurodegenerative disorders, Kidney disease models, Heart Failure, Aging","https://pmc.ncbi.nlm.nih.gov/articles/PMC4322169/, https://pmc.ncbi.nlm.nih.gov/articles/PMC9167025/, https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/",C32H49N9O5,SS-31,2025-08-14T23:04:41+00:00,2025-09-08T20:02:29+00:00,Longevity,#ECEFF1,#455A64,Heart,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
115,aod-9604,19.0,Tyr‑Leu‑Arg‑Ile‑Val‑Gln‑Cys‑Arg‑Ser‑Val‑Glu‑Gly‑Ser‑Cys‑Gly‑Phe,,"AOD9604 is a synthetic 16-amino-acid peptide derived from the C-terminal domain of human growth hormone, with an extra tyrosine at the N-terminus for stabilization.","AOD9604 retains the lipolytic effects of hGH but does not stimulate IGF‑1 production, nor does it trigger systemic growth effects. Evidence from animal studies suggests AOD9604 activates lipolytic pathways, increasing breakdown of stored triglycerides into free fatty acids and glycerol, possibly via hormone‑sensitive lipase activation and enhanced cAMP–PKA signaling. It may suppress the formation of new fat — potentially by interfering with key enzymes like acetyl-CoA carboxylase. Studies in obese mice show AOD9604 may upregulate β₃‑adrenergic receptor expression, thereby enhancing sensitivity of adipose tissue to adrenergic lipolytic stimuli. Notably, even in β₃‑AR knockout mice, some lipolytic effects persist, indicating additional mechanisms beyond this pathway. AOD9604 showed promise in osteoarthritis models by supporting cartilage structure, proteoglycan production, and anti-inflammatory pathways.",https://upload.wikimedia.org/wikipedia/commons/thumb/3/31/AOD_9604.svg/330px-AOD_9604.svg.png,"L-Tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cystinyl-L-arginyl-L-seryl-L-valyl-L-glutamyl-L-glycyl-L-seryl-L-cystinyl-L-glycyl-L-phenylalanine, cyclic (7→14)-disulfide","1,815 g/mol","Obesity, Insulin Resistance, Osteoarthritis","https://doi.org/10.1038%2Fclpt.2010.57, https://doi.org/10.1210%2Fendo.142.12.8522, https://www.jofem.org/index.php/jofem/article/view/157",C78H123N23O22S2,AOD-9604,2025-08-19T19:19:00+00:00,2025-09-27T05:09:00+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
116,semaglutide,19.0,His‑Aib‑Glu‑Gly‑Thr‑Phe‑Thr‑Ser‑Asp‑Val‑Ser‑Ser‑Tyr‑Leu‑Glu‑Gly‑Gln‑Ala‑Ala‑Lys(AEEAc‑AEEAc‑γ‑Glu‑17‑carboxyheptadecanoyl)‑Glu‑Phe‑Ile‑Ala‑Trp‑Leu‑Val‑Arg‑Gly‑Arg‑Gly‑OH,,"Semaglutide is a GLP‑1 receptor agonist, mimicking endogenous GLP‑1.","Semaglutide stimulates glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, reducing appetite and overall energy intake.",https://upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Semaglutid_3Letter.svg/500px-Semaglutid_3Letter.svg.png,,4113.64 g/mol.,"Obesity, Insulin resistance, Recomposition","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11215664/?utm_source=chatgpt.com, https://www.sciencedirect.com/topics/medicine-and-dentistry/semaglutide?utm_source=chatgpt.com",C187H291N45O59,Semaglutide,2025-08-20T00:37:55+00:00,2025-09-08T20:00:15+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
117,ace-031,19.0,Ala‑Trp‑Arg‑Gln‑Asn‑Thr‑Arg‑Tyr‑Ser‑Arg‑Ile‑Glu‑Ala‑Ile‑Lys‑Ile‑Gln‑Ile‑Leu‑Ser‑Lys‑Leu‑Arg‑Leu‑NH₂,,ACE‑031 is a fusion protein composed of the extracellular domain of human activin receptor type IIB linked to an IgG1 Fc region.,"ACE‑031 acts as a decoy receptor, binding myostatin (and activin A), preventing their interaction with native ActRIIB on muscle cells. This blocks the inhibitory signaling that restricts muscle growth, enabling increased muscle protein synthesis and hypertrophy. In mice, ACE‑031 resulted in ~16% greater body weight gain versus controls after 4 weeks, indicating broad muscle hypertrophy across fiber types.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=118732224&t=l,,2956.49 g/mol,"Atrophy, Muscle Wasting, Bodybuilding, Weight Loss","https://ncbi.nlm.nih.gov/pmc/articles/PMC2944638/?utm_source=chatgpt.com, https://pubmed.ncbi.nlm.nih.gov/23169607/?utm_source=chatgpt.com",C122H227N42O22,ACE-031,2025-08-20T00:54:57+00:00,2025-09-29T07:33:17+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
118,pe-22-28,21.0,Gly-Val-Ser-Trp-Gly-Leu-Arg,,"PE‑22‑28 is a synthetic analog of spadin, a peptide derived from sortilin. The segment corresponds to amino acid residues 22–28 of spadin.","PE-22-28 inhibits TREK-1, a channel involved in regulating mood, neuroplasticity, and neuronal excitability. TREK-1 inhibition is linked to antidepressant effects.",https://www.peptideswiki.org/wp-content/uploads/2023/01/PE-22-28.png,(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-amino-3-hydroxypropionyl]amino}-3-(1H-indol-3-yl)propanoyl]amino}-2-[(1-methylethyl)amino]-2-oxoethyl]amino}-3-hydroxypropanoyl]amino}-3-methylbutanoyl]amino}acetamide,773.9 g/mol,"Depression, Studying aid, Neuroprotection","https://pubmed.ncbi.nlm.nih.gov/28955242/, https://pubmed.ncbi.nlm.nih.gov/31325429/, https://pmc.ncbi.nlm.nih.gov/articles/PMC6470294/, https://pmc.ncbi.nlm.nih.gov/articles/PMC7665585/",C22H52N10O8,PE-22-28,2025-08-21T01:30:58+00:00,2025-09-08T19:35:40+00:00,Cognition,#E3F2FD,#1565C0,Notebook,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
119,pnc-27,20.0,H-Gly-Ser-Ile-Asn-Gln-Gln-Gln-Ser-Ser-Lys-Leu-Gln-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-NH₂,,PNC‑27 is a 32-residue chimeric peptide that combines p53-derived HDM‑2-binding domain and cell-penetrating peptide (CPP) leader sequence from the Drosophila antennapedia homeodomain.,"PNC‑27 selectively binds to HDM‑2 when it is overexpressed in the plasma membranes of cancer cells, but is minimally present in normal cell membranes. This interaction is essential for its selective cytotoxicity, as confirmed by experiments using HDM‑2-specific antibodies that block PNC‑27 killing effects. Once bound to membrane HDM‑2, PNC‑27 organizes into oligomeric, ring-shaped pores on the cancer cell membrane, leading to necrosis rather than apoptosis. Beyond plasma membrane damage, PNC‑27 enters the cancer cell and localizes to mitochondria, disrupting mitochondrial integrity and function, which contributes to cell death. PNC‑27 induces necrosis even in p53-null cancer cells (e.g., K562 leukemia), indicating its effectiveness is independent of p53 status.",https://peptide-products.com/images/products/pnc-27-structure.jpg,,4031.73 g/mol,"Cancer, Immunology","https://pmc.ncbi.nlm.nih.gov/articles/PMC2836618/?utm_source=chatgpt.com, https://pubmed.ncbi.nlm.nih.gov/38802154/?utm_source=chatgpt.com, https://aacrjournals.org/cancerres/article/68/9_Supplement/LB-195/549368/PNC-27-and-PNC-28-anticancer-peptides-selectively?utm_source=chatgpt.com, https://aacrjournals.org/cancerres/article/69/9_Supplement/884/556504/Abstract-884-Mechanism-of-action-of-PNC-27-28-anti?utm_source=chatgpt.com",C188H292N52O44S,PNC-27,2025-08-21T01:51:36+00:00,2025-09-08T19:57:32+00:00,Longevity,#ECEFF1,#455A64,Heart,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
120,cjc-1295-no-dac,4.0,Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln,"Growth hormone releasing hormone analog, Modified GNRH",CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been modified to increase its half-life and stability.,"CJC-1295 binds to and activates GHRH receptors on somatotroph cells in the anterior pituitary, stimulating the synthesis and release of growth hormone.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=91971820&t=l,,3367.88 g/mol,"Growth Hormone Deficiency, Anti-Aging, Muscle Wasting, Lipodystrophy, Metabolic Disorders","https://pubmed.ncbi.nlm.nih.gov/16352683/, https://pubmed.ncbi.nlm.nih.gov/18160750/, https://pubmed.ncbi.nlm.nih.gov/16608754/",C152H252N44O42,CJC-1295 NO DAC,2025-08-21T16:14:05+00:00,2025-09-29T07:40:14+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
121,ghrp-6,4.0,His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂,growth hormone-releasing hexapeptide,"GHRP-6 also known as growth hormone-releasing hexapeptide is a synthetic growth hormone releasing peptide (GHRP) that stimulates the release of growth hormone from the pituitary gland. GHRP-6 has a lower prolactin/cortisol spike compared to GHRP-2, making it better tolerated long-term.",GHRP-6 binds to GHS-R1a receptors in the hypothalamus and pituitary. This stimulates pulsatile release of GH and appetite. This causes indirect IGF-1 release via GH-mediated liver stimulation.,https://upload.wikimedia.org/wikipedia/commons/thumb/e/e6/GHRP-6.png/250px-GHRP-6.png,,873.01 g/mol,"Growth Hormone Deficiency, Anti-Aging, Muscle Building, Bone Density, Sleep Quality, Appetite Deficiency",https://doi.org/10.1016%2Fj.ejps.2012.10.006,C46H56N12O6,GHRP-6,2025-08-21T16:56:28+00:00,2025-08-22T00:27:27+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
122,ghrp-2,4.0,D-Ala-D-(β-naphthyl)-Ala-Trp-D-Phe-Lys-NH2,"Pralmorelin, GHRP Kaken 100, KP-102, GPA-748, WAY-GPA-748, pralmorelin hydrochloride, pralmorelin dihydrochloride, growth hormone-releasing peptide 2","GHRP-2 also known as Pralmorelin is an orally active, synthetic growth hormone releasing peptide (GHRP), specifically, an analogue of met-enkephalin, that stimulates the release of growth hormone from the pituitary gland. It is marketed by Kaken Pharmaceutical in Japan in a single-dose formulation for the assessment of growth hormone deficiency.",GHRP-2 binds to GHS-R receptors. This stimulates pulsatile release of GH and appetite. This causes indirect IGF-1 release via GH-mediated liver stimulation. It is more potent than GHRP-6 and less hunger-inducing than GHRP-6.,https://upload.wikimedia.org/wikipedia/commons/thumb/a/ac/Pralmorelin.svg/250px-Pralmorelin.svg.png,(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide,817.992 g/mol,"Growth Hormone Deficiency, Anti-Aging, Muscle Building, Bone Density, Sleep Quality, Appetite Deficiency","https://doi.org/10.2165%2F00126839-200405040-00011, https://doi.org/10.1055%2Fs-0031-1297042,",C45H55N9O6,GHRP-2,2025-08-22T00:29:41+00:00,2025-08-22T00:34:30+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
123,peg-mgf,3.0,Tyr‑Gln‑Pro‑Pro‑Ser‑Thr‑Asn‑Lys‑Asn‑Thr‑Lys‑Ser‑Gln‑Arg‑Arg‑Lys‑Gly‑Ser‑Thr‑Phe‑Glu‑Glu‑Arg‑Lys–NH₂,Pegylated Mechano Growth Factor,"PEG-MGF is a modified form of Mechano Growth Factor, a splice variant of IGF-1, designed for greater stability and systemic effect.","After muscle damage or overload, your body produces IGF-1, which can be spliced into MGF. MGF stimulates satellite cell activation and muscle repair, essentially telling the muscle to grow and regenerate. Natural MGF acts locally and degrades quickly — PEG-MGF allows for systemic circulation and longer-lasting effects.",https://www.genemedics.com/wp-content/uploads/2021/05/Pegylated-Mechano-Growth-Factor-1024x642.jpg,Poly(ethylene glycol)-conjugated IGF‑1 Ec splice variant peptide,2867–2888 g/mol,"Muscle growth, Muscle Recovery, Performance, Bone repair, Tendon repair","https://pubmed.ncbi.nlm.nih.gov/21354439/, https://pubmed.ncbi.nlm.nih.gov/27334712/",C121H200N42O39,PEG-MGF,2025-08-22T00:51:35+00:00,2025-08-22T01:25:41+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
124,foxo4-dri,20.0,H‑D‑Leu‑D‑Thr‑D‑Leu‑D‑Arg‑D‑Lys‑D‑Glu‑D‑Pro‑D‑Ala‑D‑Ser‑D‑Glu‑D‑Ile‑D‑Ala‑D‑Gln‑D‑Ser‑D‑Ile‑D‑Leu‑D‑Glu‑D‑Ala‑D‑Tyr‑D‑Ser‑D‑Gln‑D‑Asn‑Gly‑D‑Trp‑D‑Ala‑D‑Asn‑D‑Arg‑D‑Arg‑D‑Ser‑D‑Gly‑D‑Gly‑D‑Lys‑D‑Arg‑D‑Pro‑D‑Pro‑D‑Pro‑D‑Arg‑D‑Arg‑D‑Arg‑D‑Gln‑D‑Arg‑D‑Arg‑D‑L,,"FOXO4-DRI is a novel peptide designed specifically to target and eliminate senescent cells, playing a critical role in aging and age-related diseases. Derived from the FOXO4 protein, this peptide has attracted significant attention due to its potential for promoting healthy aging, improving tissue regeneration, and extending lifespan.","FOXO4‑DRI is engineered to disrupt the interaction between the transcription factor FOXO4 and p53 in senescent cells. This leads to p53 nuclear exclusion, directing it to mitochondria and activation of p53-dependent apoptosis, selectively eliminating senescent cells.
The D-retro-inverso design imparts high stability and resistance to degradation, making FOXO4‑DRI effective in cellular environments",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=167312269&t=l,,5358.06 g/mol,"Senescence, Cartilage Degeneration, Hypogonadism, Inflammation","https://pubmed.ncbi.nlm.nih.gov/33996787/, https://pubmed.ncbi.nlm.nih.gov/31959736/",C228H488N86O64,FOXO4-DRI,2025-08-22T01:16:19+00:00,2025-09-29T07:46:56+00:00,Longevity,#ECEFF1,#455A64,Heart,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
125,b7-33,27.0,Val-Ile-Lys-Leu-Ser-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Ser-Gly-Met-Ser-Thr-Trp-Ser-Lys-Arg-Ser-Leu-NH2,"GTPL9321, (B7-33)H2","B7‑33 is a synthetic peptide derived from the B‑chain of human relaxin‑2. It’s designed to mimic the hormone’s beneficial effects, particularly anti‑fibrotic and vasoprotective actions while, offering improved stability and a more selective signaling profile.","B7‑33 acts as a functionally selective agonist for the relaxin family peptide receptor 1 (RXFP1). Unlike H2 relaxin, which activates both cAMP-PKA and pERK (MAPK) pathways, B7‑33 preferentially activates the pERK pathway, minimizing cAMP-mediated effects that can include hormonal side effects or tumor promotion. Through ERK activation, B7‑33 stimulates MMP‑2 expression and promotes collagen degradation, aiding tissue remodeling and reducing fibrosis.",https://file.medchemexpress.eu/product_pic/hy-p10728.gif,,"2,986.54 g/mol","Endothelial Health, Cardioprotection, Fibrosis, Implants","https://pubmed.ncbi.nlm.nih.gov/36753958/, https://pubmed.ncbi.nlm.nih.gov/30155023/,",C131H229N41O36S,B7-33,2025-08-22T01:38:38+00:00,2025-08-31T21:14:47+00:00,Tissue Remodeling,#E3F2FD,#1565C0,Dna,2025-08-31T21:10:33+00:00,2025-08-31T21:10:33+00:00
126,mots-c,19.0,Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg,Mitochondrial Open Reading Frame of the 12S rRNA-c,"MOTS‑c is a 16‑amino‑acid peptide encoded within mitochondrial DNA. It is increasingly recognized for its role as a mitochondrial‑derived signaling peptide that regulates metabolism, insulin sensitivity, stress responses, and aging earning it the label of an “exercise mimetic”","MOTS‑c suppresses the folate cycle, reducing levels of 5‑Me‑THF, which in turn impairs de novo purine synthesis -leading to accumulation of AICAR. AICAR: activates AMPK, increases GLUT4 expression and glucose uptake, suppresses acetyl-CoA carboxylase, promoting fatty acid oxidation, stimulates mitochondrial biogenesis via PGC‑1α activation. In mouse models, MOTS‑c improves glucose tolerance and prevents age-related or high-fat diet–induced insulin resistance and obesity without affecting food intake. These effects are especially pronounced in skeletal muscle, emphasizing its role in enhancing insulin action via AMPK-mediated pathways. MOTS-c promotes mitochondrial biogenesis, enhances mitochondrial fusion, and upregulates mitophagy-related genes like PINK1 and PARK2. In MRSA‑induced sepsis models, MOTS‑c enhances survival, reduces bacterial load, and shifts cytokine balance towards anti-inflammatory, while suppressing MAPK signaling and boosting AhR and STAT3 in macrophages.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=146675088&t=l,L-methionyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-glutamyl-L-methionyl-L-glycyl-L-tyrosyl-L-isoleucyl-L-phenylalanyl-L-tyrosyl-L-prolyl-L-arginyl-L-lysyl-L-leucyl-L-arginine,2177.57 g/mol,"Mitochondrial function, Immunology, Cardiovascular Health, Insulin Resistance","https://www.spandidos-publications.com/10.3892/mmr.2025.13492?utm_source=chatgpt.com, https://pmc.ncbi.nlm.nih.gov/articles/PMC9854231/?utm_source=chatgpt.com, https://www.mdpi.com/1422-0067/23/19/11991?utm_source=chatgpt.com, https://pubmed.ncbi.nlm.nih.gov/29096170/?utm_source=chatgpt.com, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2025.1602271/full?utm_source=chatgpt.com",C99H160N25O24S2,MOTS-c,2025-08-23T02:18:22+00:00,2025-09-29T07:52:06+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
127,mazdutide,19.0,His-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Lys-Lys-Ala-Lys-{AEEA-AEEA-γGlu‑Nonadecanoic acid}-Glu-Phe-Val-Glu-Trp-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly‑NH₂,"IBI‑362, LY‑3305677","Mazdutide is a long‑acting dual agonist targeting GLP‑1 receptor and Glucagon receptor. It is a synthetic analogue of the gut hormone oxyntomodulin, engineered for extended action via a fatty‑acid side chain conjugation.","By agonizing GLP-1 and Glucagon receptors it promotes glucose‑dependent insulin secretion, reduces appetite, and slows gastric emptying, boosts energy expenditure, enhances fat metabolism, and reduces hepatic fat.",https://structimg.guidechem.com/7/31/16995030.png,,4563.1 g/mol,"Insulin Resistance, Obesity, Addiction","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232612, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561728, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374649, https://www.nejm.org/doi/full/10.1056/NEJMoa2411528",C210H322N46O67,Mazdutide,2025-08-23T02:56:01+00:00,2025-09-08T19:25:39+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
128,igf-1-des,3.0,Gly-Arg-Gly-Ala-Ser-Gly-Gly-Ser-Gly-Gly,"Des(1‑3) IGF‑1, Insulin‑like growth factor‑1 des‑(1‑3), 4‑70 insulin‑like growth factor‑1","IGF‑1 DES is a naturally occurring truncated analogue of IGF‑1, lacking the first three N‑terminal amino acids Gly‑Pro‑Glu. It has heightened biological potency, being around 10‑fold more effective than full-length IGF‑1 in stimulating cellular hypertrophy and proliferation due to greatly reduced binding to IGF binding proteins.","IGF‑1 DES binds to the IGF‑1 receptor with higher affinity and evades inhibition by IGFBPs, resulting in enhanced receptor-mediated signaling. Upon receptor activation, it triggers key anabolic pathways - PI3K/Akt and mTOR, promoting muscle protein synthesis, cell growth, and survival. With a shorter half-life of approx. 20–30 minutes, it’s especially suited for site-specific delivery, offering high local potency with reduced systemic exposure.",https://www.peptidesciences.com/media/wysiwyg/igf1-des.png,,7371.48 g/mol,"Neurology, Muscle Growth, Tissue Repair","https://pubmed.ncbi.nlm.nih.gov/8930132/, https://pubmed.ncbi.nlm.nih.gov/1281142/, https://pubmed.ncbi.nlm.nih.gov/12875741/, https://pubmed.ncbi.nlm.nih.gov/15985695/",C319H495N91O96S7,IGF-1 DES,2025-08-26T02:02:56+00:00,2025-09-08T19:22:16+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
129,survodutide,19.0,H‑His‑{Ac4c}‑Gln‑Gly‑Thr‑Phe‑Thr‑Ser‑Asp‑Tyr‑Ser‑Lys‑Tyr‑Leu‑Asp‑Glu‑Arg‑Ala‑Ala‑Lys‑Asp‑Phe‑Ile‑{GGSGSG‑γE‑C18‑diacid}‑Trp‑Leu‑Glu‑Ser‑Ala‑NH₂,"EX‑A7878, BI‑456906","Survodutide is an experimental peptide that works as a dual glucagon/GLP-1 receptor agonist. Unlike other dual GLP-1/glucagon dual agonists, it is a glucagon analog rather than an analog of oxyntomodulin. The design includes a C18 fatty diacid chain, which promotes albumin binding, thereby significantly extending its half-life for once-weekly administration","GLP‑1R activation reduces appetite, enhances insulin secretion, delays gastric emptying, and improves glycemic control.
GCGR activation increases energy expenditure, promotes lipolysis, and enhances fat metabolism, therefore helping preserve lean mass.
The peptide is acylated with a C18 fatty diacid moiety, enabling strong albumin binding and prolonged half‑life of around 109 to 115 hours, supporting once‑weekly subcutaneous administration.
It includes a non‑coded amino acid (Ac4c) at position 2, conferring resistance to DPP‑4 degradation.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=168429725&t=l,,4231.6 g/mol,"Obesity, Type 2 Diabetes, Steatohepatitis,","https://pubmed.ncbi.nlm.nih.gov/38330987/, https://pubmed.ncbi.nlm.nih.gov/38847460/, https://pubmed.ncbi.nlm.nih.gov/38857788/, https://pubmed.ncbi.nlm.nih.gov/39582349/",C192H289N47O61,Survodutide,2025-08-26T02:13:49+00:00,2025-09-29T07:56:37+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
130,thymosin-alpha-1,18.0,Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH,thymalfasin,"Thymosin α1 is a 28‑amino‑acid bioactive peptide, biologically derived from the N‑terminus of prothymosin α, and originally isolated from thymus tissue. The synthetic form, thymalfasin, is approved in over 30–35 countries for clinical use, notably against chronic hepatitis B and C, and as an immune enhancer","Tα1 enhances the maturation and differentiation of T cells, dendritic cells, and natural killer cells, and stimulates antibody production. It interacts with TLR2, TLR3, TLR4, TLR7, and TLR9, triggering downstream signaling via MyD88, NF‑κB, IRF3, MAPK, and TRAF6 to boost cytokine production and antigen presentation. Tα1 enhances levels of glutathione and activity of antioxidant enzymes, helping to mitigate oxidative stress and support tissue protection Tα1 promotes immunosurveillance via increased MHC expression, and in preclinical models, inhibits tumor growth, metastasis, and improves survival, especially when combined with chemotherapy or as adjuvant therapy.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=16130571&t=l,(2S)-N-[(2S)-2-{[(2S)-2-{[(2S)-2-{…}]}]}]-28-amino acid chain with N-terminal acetyl group and C-terminal L-asparagine,"3,108 g/mol","Viral Infections, Immunodeficiency, Sepsis & Critical Illness, Oncology, Autoimmune/Inflammatory.","https://pubmed.ncbi.nlm.nih.gov/33362999/, https://pubmed.ncbi.nlm.nih.gov/37110771/, https://pubmed.ncbi.nlm.nih.gov/36871535/, https://pubmed.ncbi.nlm.nih.gov/38308608/",C129H215N33O55,Thymosin Alpha-1,2025-08-27T03:13:31+00:00,2025-09-29T07:59:26+00:00,Immune Modulation,#EFEBE9,#4E342E,Stethoscope,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
131,hmg,4.0,,"FSH/LH, Menotropin, human menopausal gonadotropin, Fertinex, Gynogen HP, Humog, Humegon, Menopur, Merional, Meriofert, Menogon, Metrodin, Reprone, Pergonal, HMG Massone",HMG is a urine-derived gonadotropin mixture containing both FSH and LH. It is widely used in treatments for infertility - stimulating ovarian follicle development in women and spermatogenesis in men.,"FSH: Binds to receptors on ovarian follicles or Sertoli cells, stimulating follicular growth or sperm maturation.
LH: Acts on ovarian theca cells to trigger ovulation, and on Leydig cells to promote testosterone synthesis, supporting further gamete development.",,,,"Infertility, Hypogonadism","https://pubmed.ncbi.nlm.nih.gov/11157827/, https://pubmed.ncbi.nlm.nih.gov/19406028/, https://pubmed.ncbi.nlm.nih.gov/19356754/",,HMG,2025-08-27T20:41:04+00:00,2025-09-08T19:20:19+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
132,astressin-b,4.0,Ac-Asp-Leu-Ser-D-Phe-His-D-aMeLeu-Leu-Arg-Lys-Nle-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Glu-Glu-Ala-DL-Glu(1)-D-Asn-Asn-Lys(1)-Leu-Leu-Leu-Asp-D-aMeLeu-Ile-NH2,,"Astressin‑B is a synthetic peptide designed as a corticotropin-releasing factor receptor antagonist. It has been studied in preclinical models for its potential to modulate stress responses, particularly in conditions related to the hypothalamic–pituitary–adrenal axis.","By inhibiting CRF receptors, Astressin-B potently reduces stress-induced release of ACTH and cortisol. Studies in animal models have shown effects such as reduced anxiety-like behavior, amelioration of stress-related physiological changes, and modulation of gastric motility. Astressin-B is able to delay the emptying of solid food in mice. Astressin-B can prevent the release of adrenocorticotropic hormone in mice due to shock, alcohol and endotoxemia. Treatment with astressin-B caused the sudden growth of hair in mice bred to overexpress CRF.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=73350132&t=l,Ac-Asp-Leu-Ser-D-Phe-His-D-aMeLeu-Leu-Arg-Lys-Nle-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Glu-Glu-Ala-DL-Glu(1)-D-Asn-Asn-Lys(1)-Leu-Leu-Leu-Asp-D-aMeLeu-Ile-NH2,4044 g/mol,"Obesity, Sexual Health, Stress Management, Gastrointestinal Dysregulation, Hair loss, PTSD, Anxiety","https://doi.org/10.1210%2Fen.2007-1350, https://doi.org/10.1111%2Fj.1743-6109.2010.02055.x, https://doi.org/10.1152%2Fajpregu.2001.281.5.R1401, https://doi.org/10.1210%2Fen.2002-0117, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040186",C183H305N47O55,Astressin-B,2025-08-27T21:03:34+00:00,2025-09-29T07:34:42+00:00,Hormonal,#FFEBEE,#C62828,FlaskConical,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
133,aicar,19.0,5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside,"Acadesine, AICA-riboside","AICAR, is an AMP-activated protein kinase activator which is used for the treatment of acute lymphoblastic leukemia and may have applications in treating other disorders such as diabetes. Acadesine has been used clinically to treat and protect against cardiac ischemic injury. The drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery.","AICAR acts as an AMP-activated protein kinase agonist. It stimulates glucose uptake and increases the activity of p38 mitogen-activated protein kinases α and β in skeletal muscle tissue, as well as suppressing apoptosis by reducing production of reactive oxygen compounds inside the cell.",https://upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Acadesine_structure.svg/250px-Acadesine_structure.svg.png,"[(2R,3S,4R,5R)-5-(4-amino-1H-imidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",338.21 g/mol,"Metabolic Disease, Obesity, Cardiology, Cancer, Neurology","https://pubmed.ncbi.nlm.nih.gov/16176927/, https://pubmed.ncbi.nlm.nih.gov/29021780/, https://pubmed.ncbi.nlm.nih.gov/17513706/, https://pubmed.ncbi.nlm.nih.gov/25979627/, https://pubmed.ncbi.nlm.nih.gov/16567505/",C9H15N4O8P,AICAR,2025-08-27T21:35:08+00:00,2025-09-08T00:57:46+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
134,epitalon,24.0,Ala–Glu–Asp–Gly,Epithalamin,Epitalon is a synthetic tetrapeptide derived from pineal gland extract also known as epithalamin. It is noted for its anti-aging effects and was extensively studied at the St. Petersburg Institute of Bioregulation and Gerontology under Khavinson’s supervision. Its one of the most researched Khav peptides which were all researched under Khavinson's supervision.,"Epitalon induces telomerase activity, leading to telomere elongation in human somatic cells, potentially extending cellular lifespan and bypassing replicative senescence. It binds to histones,especially H1/3 and H1/6, modulating chromatin structure and promoting gene expression tied to neurogenesis and cellular rejuvenation. It enhances antioxidant enzyme activity and shows potential in reducing tumor development and metastasis in animal models. Improves melatonin secretion and normalizes circadian rhythm, with broader neuroendocrine regulatory roles.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=219042&t=l,(4S)-4-[[(2S)-2‑aminopropanoyl]amino]-5‑[[(2S)-3‑carboxy-1‑(carboxymethylamino)-1‑oxopropan-2‑yl]amino]-5‑oxopentanoic acid,390.35 g/mol,"Anti-Aging, Neurology, Neurodegeneration, Endocrine Regulation, Circadian Regulation, Gerontology","https://pubmed.ncbi.nlm.nih.gov/40141333/, https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10570?sid=nlm%3Apubmed, https://pubmed.ncbi.nlm.nih.gov/40908429/, https://pubmed.ncbi.nlm.nih.gov/32019204/",C14H22N4O9,Epitalon,2025-08-30T07:27:56+00:00,2025-09-08T19:15:34+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
135,pinealon,24.0,Glu–Asp–Arg,EDR,"EDR is a neuroprotective tripeptide also studied by Khavinson’s group. It’s implicated in preventing neurodegenerative progression and supporting neuronal function, particularly in Alzheimer’s disease models","Epitalon binds to histones and/or RNA, modulates MAPK/ERK signaling, and influences transcription factors (e.g., PPARA, PPARG) as well as apoptotic and antioxidative proteins (e.g., caspase‑3, p53, SOD2, GPX1). It provides a stabilizing effect against homocysteine-induced neurotoxicity by modulating ERK activation timing and reducing ROS-mediated damage. In Alzheimer’s mouse models (5xFAD), Pinealon and Vesugen preserve dendritic spine integrity and enhance neuroplasticity; docking studies suggest specific promoter-level epigenetic effects.",https://www.corepeptides.com/wp-content/uploads/2024/09/Pinealon-Peptide-Structure.jpg,(4S)-4-Amino-5-[[(2S)-3-carboxy-1-[[(1S)-1-carboxy-4-(diaminomethylideneamino)butyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,418.407 g/mol,"Neurodegeneration, Neuroplasticity, Oxidative Stress, Athletic Performance, Metabolic Health, Cell Survival","https://pubmed.ncbi.nlm.nih.gov/28509493/, https://pubmed.ncbi.nlm.nih.gov/26390612/, https://pmc.ncbi.nlm.nih.gov/articles/PMC7795577/, https://pubmed.ncbi.nlm.nih.gov/22567179/, https://pubmed.ncbi.nlm.nih.gov/21978084/",C15H26N6O8,Pinealon,2025-08-30T08:04:59+00:00,2025-09-08T19:55:27+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
136,vesugen,24.0,Lys–Glu–Asp,"Lysyl‑glutamyl‑aspartic acid, SCHEMBL3767701, Vitalis",Vesugen is a synthetic bioregulatory tripeptide also studied by Khavinson’s group. Primarily focused on vascular rejuvenation and systemic geroprotection.,"Vesugen binds to gene promoter regions, influencing the expression of proteins such as Ki‑67 , SIRT1, endothelin‑1, connexins, VEGF, and p53, which play pivotal roles in vascular repair and aging. It enhances endothelial function, promoting NO-dependent vasorelaxation, improved extracellular matrix integrity, blood vessel elasticity, and red blood cell membrane stability. It suppresses SASP  markers like p16, p21, reduces telomeric damage, reduces endothelin‑1, increases SIRT1, improves mitochondrial function, and protects telomeric stability in endothelial cells. Vesugen supports synaptic plasticity and neuronal structures in Alzheimer's models preserving dendritic spines, enhancing long-term potentiation, and promoting stem cell differentiation.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=87571363&t=l,(2S)-2‑amino‑butanoyl]amino]butanedioic acid (a structuring reflecting a Lys–Glu–Asp peptide),390.39 g/mol,"Endothelial Dysfunction, Anti-Aging, Metabolic Disorder, Cognition, Injury Regenerative, Immunology","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227791/, https://pubmed.ncbi.nlm.nih.gov/28539025/, https://pubmed.ncbi.nlm.nih.gov/22808515/, https://pubmed.ncbi.nlm.nih.gov/18546825/, https://pubmed.ncbi.nlm.nih.gov/26390612/",C15H26N4O8,Vesugen,2025-08-30T09:54:19+00:00,2025-08-30T13:09:13+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
137,cortexin,21.0,,"neuropeptide complex, tissue-derived peptide preparation, Geropharm","Cortexin is a neuropeptide complex derived from the cerebral cortex of young animals (cattle/pigs) under 12 months old. It represents a highly purified fraction of peptides—predominantly acidic and neutral—with an isoelectric point ranging between pH 3.5–9.5 and molecular weights of 1,000–10,000 Da. his preparation is used in clinical settings within Russia and some post‑Soviet countries as a neuroprotective and neurometabolic agent, employed in cases ranging from stroke and brain injury to developmental and cognitive disorders in both pediatric and adult patients.","Cortexin binds to key glutamatergic and GABAergic receptors, including: AMPA receptors, Kainate receptors, mGluR1, GABA_A1, mGluR5. Cortexin inhibits caspase-8, a key enzyme in the initiation of apoptosis. It shows lower or no activity against other proteases like caspase-1, -3, -9, cathepsin B, or calpain. This inhibition contributes to its neuroprotective effect in models of excitotoxicity. ortexin modulates the balance of excitatory/inhibitory neurotransmitters: enhancing GABA and serotonin, modulating dopamine release, and restoring neurochemical homeostasis. It also exerts antioxidant and anti-apoptotic protection, reducing lipid peroxidation and oxidative stress. It demonstrated ability to stimulate axonal and dendritic outgrowth, influence expression of neurotrophic factors, and support neural repair and plasticity.",,,"1,000–10,000 g/mol","Brain Ischemia, Cognitive Disorders, Behavioral Disorders, Epilepsy, Ototoxicity Protection, Neuroplasticity, Neuroprotection,","https://pubmed.ncbi.nlm.nih.gov/26356623/, https://pubmed.ncbi.nlm.nih.gov/34260655/, https://link.springer.com/article/10.1007/s11055-019-00839-4, https://pubmed.ncbi.nlm.nih.gov/33834730/, https://pubmed.ncbi.nlm.nih.gov/40299434/, https://pubmed.ncbi.nlm.nih.gov/29652302/, https://pubmed.ncbi.nlm.nih.gov/19672239/",,Cortexin,2025-08-30T12:56:47+00:00,2025-09-08T01:28:53+00:00,Cognition,#E3F2FD,#1565C0,Notebook,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
138,thymalin,24.0,Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn,,"Thymalin is a synthetic peptide derived from thymulin, a small peptide hormone originally extracted from the thymus gland in 1977. It is primarily investigated for immune modulation, anti-aging, and regenerative medicine applications.","Thymalin's mechanism is extremely multifaceted. It enhances T‑cell differentiation, activates natural killer cells, promotes balanced cytokine production, and helps restore immune balance. It supports protein synthesis, tissue healing, reduces systemic inflammation, and stabilizes homeostasis. It may affect the hypothalamic-pituitary-adrenal axis, modulate circadian-related immune decline, and influence astrocyte function in the CNS. Thymalin has demonstrated anti-aging potential. It enhances treatment outcomes in cancer, tuberculosis, psoriasis, chronic kidney inflammation, and cardiovascular diseases by improving immune surveillance and cellular function.",,,858.9 g/mol,"Immune Support, Anti-aging, Cancer Adjuvant, Cardiovascular Health, Infections, Neuroprotection, Circadian Rhythm","https://pubmed.ncbi.nlm.nih.gov/33237528/, https://pmc.ncbi.nlm.nih.gov/articles/PMC8365293/, https://www.mdpi.com/1422-0067/24/17/13377, https://link.springer.com/article/10.1007/s10517-020-05016-z",C33H54N12O15,Thymalin,2025-08-31T21:42:07+00:00,2025-09-09T16:04:44+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
139,vilon,24.0,Lys–Glu,"Lysylglutamate, Normophthal, Lys-glutamic acid","Vilon is a synthetic dipeptide, the shortest peptide recognized for biological activity. It’s considered a bioregulator due to its role in modulating immune function, tissue repair, anti-aging, and gene expression. It was developed based on analyses of thymus tissue extracts similiar to Thymalin.","Vilon reportedly interacts with chromatin, loosening tightly packed DNA similiar to HDAC inhibitors and reactivating transcription of genes crucial for cellular repair and protein synthesis. It stimulates immune cell activity, including T-lymphocytes and thymocytes, enhancing receptor expression on T/B cells, increasing cytokines like interleukins and interferons, and boosting argyrophilic nucleolar protein synthesis. Additional effects include increasing antithrombin III and protein C, enhancing fibrinolysis, improving vascular and metabolic homeostasis, and supporting organ-specific gene expression.",https://www.peptidesciences.com/media/wysiwyg/Vilon_Structure.png,"2-(2,6-Diaminohexanoylamino)pentanedioic acid",257.30 g/mol,"Immune System, Tissue Regeneration, Anti-Aging, Longevity, Cardiovascular, Neurological Disease, Cancer, Metabolism, Resilience","https://pubmed.ncbi.nlm.nih.gov/15105581/, https://pubmed.ncbi.nlm.nih.gov/16142267/, https://pubmed.ncbi.nlm.nih.gov/16705247/, https://pubmed.ncbi.nlm.nih.gov/16075684/",C11H21N3O5,Vilon,2025-09-01T01:31:39+00:00,2025-09-08T20:15:16+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
140,livagen,24.0,H‑Lys‑Glu‑Asp‑Ala‑OH,,Livagen is a synthetic tetrapeptide composed of four amino acids which has been shown to restore protein synthesis in aging cells and has also been shown to inhibit enkephalin degradation.,"Livagen appears to decondense chromatin similiar to HDAC inhibitors, thereby reactivating silenced genes, especially ribosomal genes, which enhances protein synthesis, particularly in aged cells. It also inhibits enkephalin-degrading enzymes, raising levels of the body’s own opioid peptides. By modulating enkephalin levels, it may enhance mucosal protection, alter nitric oxide and prostaglandin signaling, and increase vagal nerve activation. Is also proposed to support DNA repair, telomerase activity, oxidative stress reduction, and neuroprotection.",https://peptidescalculator.com/assets/Livagen1-Dx7iYLFc.png,,461.5 g/mol,"Anti-Aging, Rejuvenation, Immune System, Pain, Mental Health, Neuroprotection, Injury Recovery","https://pubmed.ncbi.nlm.nih.gov/16075683/, https://pubmed.ncbi.nlm.nih.gov/12533768/, https://pubmed.ncbi.nlm.nih.gov/35986358/, https://pubmed.ncbi.nlm.nih.gov/12577697/, https://pubmed.ncbi.nlm.nih.gov/37042594/",C18H31N5O9,Livagen,2025-09-01T02:27:41+00:00,2025-09-08T19:23:58+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
141,cartalax,24.0,Ala–Glu–Asp,"AED, T‑31, Alanyl‑glutamyl‑aspartic acid",Cartalax is a synthetic tripeptide bioregulator originating from the Russian peptide regimens developed at the St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson. It shows promise in supporting connective and cartilage tissue health.,"Cartalax boosts cell proliferation, reduces apoptosis via p53 downregulation and improves fibroblast function across tissues like skin, cartilage, and kidneys. It inhibits MMP‑9, an enzyme that accelerates tissue breakdown during aging, and balances other MMPs (like MMP‑1) to harmonize tissue remodeling. Cartalax appears to influence gene networks related to aging markers such as IGF1, FOXO1, TERT, TNKS2, and NF‑κB, inducing changes ranging from 1.6- to 5.6-fold in tissues such as bone marrow stem cells. It may support cartilage and bone health by promoting extracellular matrix integrity and reducing inflammation. In renal models, Cartalax increases proliferation markers, decreases aging markers like p16, p21, and p53, and enhances SIRT‑6 expression, supporting longevity at the cellular level.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=87815447&t=l,(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxybutanoyl]amino]butanedioic acid,333.29 g/mol,"Arthritis, Anti-Aging, Kidney Health, Tissue Remodeling","https://www.researchgate.net/publication/356507113_Peptide_Regulation_of_Gene_Expression_A_Systematic_Review, https://pubmed.ncbi.nlm.nih.gov/15516882/, https://pubmed.ncbi.nlm.nih.gov/20632718/, https://pubmed.ncbi.nlm.nih.gov/18274484/, https://pubmed.ncbi.nlm.nih.gov/18357761/",C12H19N3O8,Cartalax,2025-09-01T23:31:28+00:00,2025-09-08T01:12:59+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
142,endoluten,24.0,,A‑8 pineal peptide bioregulator,"Endoluten is a natural peptide complex derived from the pineal gland of young animals, commonly calves up to 12 months old. It was developed within the framework of Russian peptide bioregulator research, notably by Professor Vladimir Khavinson and colleagues.","Endoluten targets pineal gland and neuroendocrine cells to help normalize melatonin production, thereby adjusting circadian rhythms and systemic hormonal balance. It reportedly influences protein synthesis, telomere maintenance, and cellular division capacity, contributing to anti-aging effects in cellular models. The peptide complex exhibits antioxidant properties, helps regulate metabolic processes within neuroendocrine tissues, and supports adaptation to stress or extreme conditions. In studies involving patients post-radiation or chemotherapy, Endoluten improved leukocyte and lymphocyte counts, enhancing immune function and aiding recovery",,,,"Neuroendocrine Modulation, Anti-Anging, Adaptation Support, Immune System","https://archive.org/details/metabolicandendo0000tepp/page/n3/mode/2up, https://pubmed.ncbi.nlm.nih.gov/3234198/, https://www.amazon.com/Melatonin-Miracle-Age-Reversing-Disease-Fighting-Sex-Enhancing/dp/1857024605, https://khavinson.info/research/peptide-regulation-of-ageing, https://pubmed.ncbi.nlm.nih.gov/12802438/",,Endoluten,2025-09-01T23:51:12+00:00,2025-09-09T16:15:02+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
143,prostatilen,24.0,,Bovine prostate peptide extract,Prostatilen is a bioregulatory peptide complex derived from the prostate gland tissue of bulls. It belongs to a class of organ-specific peptide extracts and was first developed in the 1980s in Russia.,"As a low-molecular-weight peptide extract, Prostatilen can penetrate cells and the nucleus, interacting with gene promoter regions. This interaction modulates gene expression, promoting transcription and protein synthesis for functional restoration. It enhances synthesis of anti-histamine and anti-serotonin antibodies and inhibits MCP‑1-driven immune cell migration, reducing inflammation and Stimulates T‑lymphocytes, NK cells, and phagocytosis. In prostate and bladder it reduces platelet aggregation and coagulation, increases fibrinolytic activity, enhances microvascular blood flow, and modulates the detrusor muscle in a context-dependent manner, enhancing activity when low and suppressing when hyperactive, therefore restoring normal bladder function. It also Stimulates regeneration in aging prostate cell cultures, counteracting degeneration and age-related involutional changes. Other than that it also seems to lower lipids and enhance monoamines.",,,,"Prostate Disease, Urinary Tract Disease, Infertility, Urinary Disorders","https://pubmed.ncbi.nlm.nih.gov/1823682/, https://pubmed.ncbi.nlm.nih.gov/2058122, https://pubmed.ncbi.nlm.nih.gov/14708243/, https://pubmed.ncbi.nlm.nih.gov/17315707/, https://pubmed.ncbi.nlm.nih.gov/23116023/",,Prostatilen,2025-09-02T02:17:39+00:00,2025-09-08T19:58:33+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
144,retinalamin,24.0,,cattle retinal polypeptides,"Retinalamin is a peptide bioregulator derived from bovine retinal tissue, created by the St. Petersburg Institute of Bioregulation and Gerontology and formulated as a complex of water‑soluble polypeptide fragments.","Retinalamin enhances metabolic processes in retinal tissues, normalizes cellular membrane function, and boosts intracellular protein synthesis. It regulates lipid peroxide oxidation, prevents glutamate-induced excitotoxicity, and optimizes Müller glia activity all of which contribute to cell protection against oxidative stress. Retanalamin  promotes retinal repair and protection by promoting interaction between the retinal pigment epithelium and photoreceptors, reducing local inflammation, normalizing vascular permeability, and stimulating regeneration of retinal neurons. It also seems to improve ocular blood flow and support energy metabolism in retinal tissues",,,,"Retinal Damage, Optic Nerve Damage, Retinal Dystrophy","https://pubmed.ncbi.nlm.nih.gov/34726859/, https://pubmed.ncbi.nlm.nih.gov/34726859/, https://pubmed.ncbi.nlm.nih.gov/25306728/, https://pubmed.ncbi.nlm.nih.gov/16676805/, https://pubmed.ncbi.nlm.nih.gov/39569781",,Retinalamin,2025-09-02T02:44:23+00:00,2025-09-16T16:18:41+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
145,crystagen,24.0,Pro-Glu-Asp,"AC‑6 peptide complex, prolyl-glutamyl-aspartic acid",Crystagen®  is a short synthetic peptide designed as an immune system bioregulator by the St. Petersburg's Institute of Bioregulation intended for age-related immune decline.,"Crystagen enhances T-lymphocyte activity, modulates CD3+, CD4+/CD8+ ratios, and activates B-cell function, particularly in aged or immunocompromised models. Has demonstrated geroprotective effects, maintaining thymic cortex-medulla structure and increasing proliferation markers. Has been demonstrated to improve stress resilience, HSP gene expression, and reduced respiratory infection rates.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=145457458&t=s,(2S)-2-[[(2S)-4-carboxy-2-[[(2S)-pyrrolidine-2-carbonyl]amino]butanoyl]amino]butanedioic acid,359.34 g/mol,"Immune System, Thymus Regeneration, Stress, Infection","https://pubmed.ncbi.nlm.nih.gov/28976144/, https://www.researchgate.net/publication/223966698_Effect_of_Tripeptides_on_Lymphoid_and_Stem_Cells",C14H21N3O8,Crystagen,2025-09-02T03:25:55+00:00,2025-09-08T01:36:38+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
146,sigumir,24.0,,"Cartilage Peptide Bioregulator A‑4, Peptide complex A‑4","Sigumir is a natural peptide bioregulator complex derived from the cartilage and bone tissues of young animals, typically calves under 12 months old. The peptides are low molecular weight and extracted via patented ultrafiltration processes.","Sigumir’s peptides exhibit selective action on cartilage and bone cells, enhancing metabolism and cell trophism, therefore improving nourishment and maintenance of those tissues. By regulating metabolic processes in cartilage tissue, Sigumir helps normalize cartilage function, potentially slowing degenerative changes associated with aging. The peptide complex may promote chondrocyte activity and extracellular matrix synthesis, enhancing joint flexibility, bone density, and recovery from degeneration. It may modulate inflammatory responses in joint tissue, leading to reduced pain perception and improved range of motion.",,,,"Inflammation, Pain Management, Arthritis, Flexibility, Bone Density,","https://pubmed.ncbi.nlm.nih.gov/22708467/, https://pubmed.ncbi.nlm.nih.gov/37782637/, https://pubmed.ncbi.nlm.nih.gov/32132215/",,Sigumir,2025-09-02T16:29:43+00:00,2025-09-08T20:01:53+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
147,ventfort,24.0,,"blood vessel peptide bioregulator, Cytomaxes A‑3 complex","Ventfort, also referred to as a blood vessel peptide bioregulator, is a natural peptide complex derived from the aortic tissues of young animals, typically calves under 12 months old. It belongs to the Cytomaxes class of bioregulators -  tissue-derived peptide extracts aimed at nourishing their corresponding human tissues. Vesugen is the synthetic tripeptide active core.","Ventfort’s peptides are preferentially taken up by vascular wall cells to improve cell trophism, normalize metabolism, and restore functional and morphological integrity of vessel walls. It has been demonstrated to improve lipids and atherosclerosis. Has displayed epigenetic regulation of vascular genes: downregulation of endothelin-1, upregulation of SIRT1, normalization of connexin expression, and modulation of Ki-67, p53, and E‑selectin for enhanced cell renewal and inhibition of atherosclerotic plaque formation. Interestingly studies suggest it may support neurovascular health by stimulating serotonin synthesis in aging cortical cells and partially restoring dendritic spine density under amyloid-induced stress.",,,,"Angio‑protection, Atherosclerosis, Hyperlipidemia, Endothelial Dysfunction, Neurodegenerative DIsease","https://www.antiaging-systems.com/articles/clinical-study-of-the-biologically-active-peptide-bioregulator-ventfort/, https://pubmed.ncbi.nlm.nih.gov/24003726/, https://pubmed.ncbi.nlm.nih.gov/19830585/, https://pubmed.ncbi.nlm.nih.gov/27909961/",,Ventfort,2025-09-02T17:51:21+00:00,2025-09-08T20:14:15+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
148,bronchogen,24.0,Ala‑Glu‑Asp‑Leu,"AEDL, Bronchial peptide bioregulator","Bronchogen is a synthetic tetrapeptide bioregulator, derived from the work led by Vladimir Khavinson  at the St. Petersburg Institute of Bioregulation. Bronchogen is designed to regulate lung tissue health, in particular the bronchial epithelium.","Bronchogen increases DNA melting temperature by ~3 °C in in vitro assays, indicating it reinforces genetic stability. It preferentially binds to certain DNA sequences, potentially influencing methylation sites and gene expression via epigenetic pathways. It regulates critical lung-development genes essential for bronchial epithelial function and differentiation. It promotes bronchial epithelium regeneration and protection by increasing surfactant production and modulating inflammatory cytokines. Lastly it supports airway barrier maintenance and immunoregulation.",https://www.peptidesciences.com/media/wysiwyg/Bronchogen_Molecule.png,Ala‑Glu‑Asp‑Leu,446.45 g/mol,"Respiratory Health, Age-related Respiratory Decline, DNA Integrity","https://pubmed.ncbi.nlm.nih.gov/30199201/, https://pubmed.ncbi.nlm.nih.gov/21240358/, https://pubmed.ncbi.nlm.nih.gov/22808515/, https://link.springer.com/article/10.1007/s10517-015-3047-x",C18H30N4O9,Bronchogen,2025-09-02T18:42:49+00:00,2025-09-08T01:09:37+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
155,hgh-fragment-176-191,19.0,Tyr‑Leu‑Arg‑Ile‑Val‑Gln‑Cys‑Arg‑Ser‑Val‑Glu‑Gly‑Ser‑Cys‑Gly‑Phe,,"HGH Fragment 176‑191 is a synthetic peptide derived from the C‑terminal region of human growth hormone, specifically amino acids 176–191.","Fragment 176‑191 appears to activate fat-cell pathways promoting lipolysis, while simultaneously inhibiting lipogenesis. The fragment may enhance beta‑3 adrenergic receptor expression in adipose tissue, increasing fat burning in fat cells and possibly skeletal muscle thermogenesis, without broadly triggering growth pathways. Unlike full-length growth hormone, it appears not to increase IGF‑1 levels or affect insulin resistance, making its effects more adipose-specific.",https://upload.wikimedia.org/wikipedia/commons/thumb/c/c9/Human_Growth_Hormone_Fragment_176-191.svg/330px-Human_Growth_Hormone_Fragment_176-191.svg.png,H-Phe-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH,1815 g/mol,"Obesity, Recomposition, Insulin Resistance","https://pubmed.ncbi.nlm.nih.gov/35783198/, https://pubmed.ncbi.nlm.nih.gov/645904/,",C78H125N23O23S2,HGH Fragment 176-191,2025-09-07T21:07:41+00:00,2025-09-08T19:19:37+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
149,pancragen,24.0,Lys–Glu–Asp–Trp,KEDW,"Pancragen is a synthetic tetrapeptide bioregulator, a structural analog of a naturally occurring peptide extracted from pancreatic tissues of young animals. Developed through Russian bioregulator research under the guidance of Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation, Pancragen is aimed at preserving pancreatic function as part of anti-aging strategies.","Pancragen penetrates cell membranes and interacts with nuclear or epigenetic machinery, promoting transcription of pancreatic differentiation. It upregulates anti-apoptopic pathways like MMP-2, MMP-9, CD79α, Mcl-1 and proliferative markers like PCNA, Ki-67. It downregulates pro-apoptopic pathway p53. It also affects other aging markers like caspase-3, cathepsin B, TNF-α and IGF-1. It modulates epigenetics by altering DNA methylation in promoter regions of PDX1, PAX6, NGN3, restoring gene expression profiles closer to a younger individual's, in pancreatic cells. Additionally it improves glucose homeostasis by lowering fasting glucose and insulin and enhancing insulin sensitivity and endothelial function, including improved adhesive properties in hyperglycemic models.",https://www.peptidesciences.com/media/wysiwyg/Pancragen_Molecule.png,Lys–Glu–Asp–Trp,576.25 g/mol,"Insulin Resistance, Anti-Aging, Pancreatic Health, Epigenetic Modulation, Vascular Health, Metabolic Health","https://pubmed.ncbi.nlm.nih.gov/23486591/, https://pubmed.ncbi.nlm.nih.gov/25946840/, https://pubmed.ncbi.nlm.nih.gov/22448364/, https://pubmed.ncbi.nlm.nih.gov/18642713/, https://www.researchgate.net/publication/236042871_Effects_of_Pancragen_on_The_Differentiation_of_Pancreatic_Cells_During_Their_Ageing",C26H36N6O9,Pancragen,2025-09-02T20:07:47+00:00,2025-09-08T19:32:49+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
150,testoluten,24.0,,"peptide complex A‑13, Testes Peptide Bioregulator A‑13","Testoluten is a natural peptide bioregulator complex derived from the testicular tissue of young animals. It contains the peptide complex A‑13, a collection of low-molecular-weight peptides designed to support testicular function and overall male reproductive health. Long-term usage in animal models has reportedly increased average lifespan by 20–40%, while in human applications, widespread physiological improvements and reduced mortality over 6–12 years have been observed.","Testoluten’s peptides target testicular cells, supporting their metabolic function and vitality. It regulates cellular metabolism and gene expression to enhance protein synthesis in testicular cells, restores hormones production, enhances spermatogenesis and sperm motility.",,,,"Sexual Health, Fertility, Hypogonadism, Testicular Hypofunction","https://pubmed.ncbi.nlm.nih.gov/19830585/,",,Testoluten,2025-09-02T23:35:47+00:00,2025-09-08T20:06:11+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
151,chonluten,24.0,Glu‑Asp‑Gly,"EDG tripeptide, T‑34 tripeptide, Glutamyl‑aspartyl‑glycine, EDG","Chonluten is a short, synthetic peptide originally derived from lung or bronchial tissues. Developed by researchers at the Saint Petersburg Institute of Bioregulation and Gerontology, led by Dr. Vladimir Khavinson, Chonluten was identified among short peptides with the potential for organ-specific regeneration and immune modulation, especially targeting the respiratory system.","Chonluten is thought to penetrate nuclei and interact with DNA or chromatin, influencing gene expression via transcriptional or epigenetic mechanisms. Chonluten is suggested to module expression of c-Fos, HSP70, SOD, COX-2, TNF‑α and others. Chonluten suppresses inflammatory cytokine production like IL-6, TNF‑α and IL-17. It supports mucosal barrier restoration in bronchial epithelium and stabilizes mucosal integrity and accelerates repair in GI tissues.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=194641&t=s,(4S)-4-amino-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,319.27 g/mol,"Respiratory Health, Post-infection Recovery, Gastrointestinal Tract Repair, Anti-Aging","https://pubmed.ncbi.nlm.nih.gov/19830585/, https://go.gale.com/ps/i.do?id=GALE%7CA356581333&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=00074888&p=AONE&sw=w&userGroupName=anon%7E6535b979, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323678/, https://pubmed.ncbi.nlm.nih.gov/34834147/, https://pubmed.ncbi.nlm.nih.gov/22803148/, https://pubmed.ncbi.nlm.nih.gov/32987757/",C11H17N3O8,Chonluten,2025-09-03T00:05:09+00:00,2025-09-08T01:26:01+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
152,thyreogen,24.0,,"Complex A‑2, Thyroid Peptide Bioregulator A‑2, Cytomaxes A‑2 complex","Thyreogen is a natural peptide bioregulator complex composed of thyroid tissue-derived peptides harvested from the thyroid glands of young animals. It is designed to normalize thyroid gland metabolism and function, acting effectively in both hypo- and hyperthyroidism scenarios.","Thyreogen is composed of short signaling peptides that penetrate thyroid cell nuclei and bind to specific DNA promoter sequences, activating RNA polymerase and initiating gene transcription - essentially restoring normal metabolic function in thyroid cells. Interestingly it exhibits a bidirectional regulatory effect of upregulating thyroid function if its hypoactive and downregulating it if its hyperactive. Lastly it supports tissue regeneration through epigenetic and gene expression mechanisms, promoting a balanced thyroid state.",,,,"Metabolic Health, Thyroid Dysfunction, Age-related Thyroid Decline, Endocrine Balance",https://pubmed.ncbi.nlm.nih.gov/17003018/,,Thyreogen,2025-09-03T02:29:50+00:00,2025-09-09T16:03:09+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
153,nephrilin,3.0,Ac‑RGVTEDYLRLETLVQKVVSKGFYKKKQCRPSKGRKRGFCW‑amide,"mTORC2 inhibitor peptide, PRR5-MBD fusion peptide","Nephrilin is a synthetic peptide specifically designed to inhibit mTORC2 short for mammalian target of rapamycin complex 2 by competing with its interaction with PRR5/Protor. It incorporates both a PRR5-derived segment and the metal-binding domain of IGFBP‑3 for targeted cellular uptake, particularly stressed cells, via iron-uptake pathways.","Nephrilin competes with PRR5 for binding to mTORC2, thereby reducing its activity. Given mTORC2’s role in activating AGC kinases, this interference can modulate stress and survival pathways. The MBD domain binds ferrous/ferric iron and facilitates peptide entry via transferrin receptor and integrin-β3, targeting stressed cells with altered iron metabolism. Nephrilin reverses ROS generation and oxidative stress markers such as p66shc phosphorylation, Ser36, NADPH oxidase activation, and inflammatory cytokine elevations. Lastly it modulates pathways connected to oxidative metabolism and stress responses involving Rac1, PKC-β, Prex1.",,,4.5–5 kDa,"Burn Trauma, Sepsis, Shock, Oxidative Stress, Epigenetic Remodeling, Anti-Aging, Metabolic Health, Regeneration","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522666/, https://journals.sagepub.com/doi/full/10.1177/2059513120939443, https://www.ijbt.org/files/ijbt1308003.pdf, https://pmc.ncbi.nlm.nih.gov/articles/PMC3828741/",,Nephrilin,2025-09-03T02:50:45+00:00,2025-09-08T19:29:08+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
170,chelohart,24.0,,"peptide complex A‑14, bioregulator of cardiac muscle peptides",Chelohart is a peptide complex produced by the St. Petersburg Institute of Bioregulation and Gerontology. It is a natural peptide extract derived from the heart tissue of young animals.,"Chelohart peptides act selectively on cardiac muscle cells. It is believed to help normalize metabolic processes in heart muscle cells by improving protein synthesis, protein turnover and restoring optimal functioning of cardiomyocytes. It is also used for reducing or preventing atrophic or degenerative changes in heart muscle.",,,,"Myocardial Function, Cardiovascular Disease, Cardiac Insufficiency, Ischemic Heart Disease",,,Chelohart,2025-09-21T00:04:48+00:00,2025-09-21T00:08:50+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
156,follistatin,28.0,MVRARHQPGGLCLLLLLLCQFMEDRSAQAGNCWLRQAKNGRCQVLYKTELSKEECCSTGR LSTSWTEEDVNDNTLFKWMIFNGGAPNCIPCKETCENVDCGPGKKCRMNKKNKPRCVCAP DCSNITWKGPVCGLDGKTYRNECALLKARCKEQPELEVQYQGRCKKTCRDVFCPGSSTCV VDQTNNAYCVTCNRICPEPASSEQYLCGNDGVTYSSACHLRKATCLLGRSIGLAYEGKCI KAKSCEDIQCT,"FST, Activin-binding protein, FS‑344, FS‑315, FS‑288, FSP","Follistatin is a secreted glycoprotein that binds and antagonizes several members of the TGF‑β superfamily. Initially discovered as a factor that suppresses follicle-stimulating hormone secretion, it has a broader physiological role in regulating cell differentiation, embryogenesis, and tissue regeneration.","Follistatin binds and neutralizes activin, myostatin, and other TGF‑β ligands, preventing them from interacting with their receptors and propagating downstream signaling. By inhibiting myostatin, follistatin removes an inhibitory checkpoint on muscle hypertrophy and hyperplasia, enhancing muscle growth and regeneration. Follistatin suppresses FSH release by neutralizing activin in the pituitary, modulating reproductive hormone dynamics. It regulates BMP signaling, influencing bone formation, cartilage induction, and embryonic axis formation.",https://upload.wikimedia.org/wikipedia/commons/thumb/0/06/PDB_2b0u_EBI.jpg/250px-PDB_2b0u_EBI.jpg,,"38,006.8 g/mol","Tissue Regeneration, Muscle Growth, Endocrinology","https://pubmed.ncbi.nlm.nih.gov/27787698/, https://pmc.ncbi.nlm.nih.gov/articles/PMC2393740/, https://pubmed.ncbi.nlm.nih.gov/23249626/, https://pubmed.ncbi.nlm.nih.gov/39300291/, https://pubmed.ncbi.nlm.nih.gov/20368179/","38,006.8 g/mol",Follistatin,2025-09-07T21:25:50+00:00,2025-09-08T19:16:57+00:00,Anabolic,#E3F2FD,#1565C0,Syringe,2025-09-07T21:23:32+00:00,2025-10-05T08:41:38+00:00
157,vasoactive-intestinal-peptide,13.0,H‑His‑Ser‑Asp‑Ala‑Val‑Phe‑Thr‑Asp‑Asn‑Tyr‑Thr‑Arg‑Leu‑Arg‑Lys‑Gln‑Met‑Ala‑Val‑Lys‑Lys‑Tyr‑Leu‑Asn‑Ser‑Ile‑Leu‑Asn‑NH₂,"VIP, Aviptadil, Vasoactive Intestinal Polypeptide, VIP acetate","VIP is a neuropeptide discovered in 1970 from porcine duodenum. It belongs to the secretin/glucagon peptide family and is widely produced in the gut, pancreas, central nervous system, heart, lungs, and immune cells.","VIP binds to GPCRs VPAC1 and VPAC2, activating adenylate cyclase, increasing intracellular cAMP, and triggering PKA-mediated signaling. It functions as a potent vasodilator, promotes smooth muscle relaxation, raises heart rate, enhances glycogenolysis, and reduces blood pressure. In immune cells, VIP suppresses pro-inflammatory pathways and promotes anti-inflammatory programs, including Treg induction and IL‑10 upregulation. VIP safeguards epithelial cells by improving mitochondrial energy production and attenuating oxidative/apoptotic injury during inflammation or radiation exposure. It also supports progenitor cell proliferation and secretory differentiation via p38 MAPK.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=53314964&t=l,,"3,325 g/mol","Immunology, Epithelial Health, Neuroprotection, Endothelial Dysfunction","https://pubmed.ncbi.nlm.nih.gov/31559013/, https://pubmed.ncbi.nlm.nih.gov/38061549/, https://pubmed.ncbi.nlm.nih.gov/33446759/, https://pubmed.ncbi.nlm.nih.gov/1901391/, https://pubmed.ncbi.nlm.nih.gov/730072/, https://pmc.ncbi.nlm.nih.gov/articles/PMC4073931/",C147H238N44O42S,Vasoactive Intestinal Peptide,2025-09-07T22:54:56+00:00,2025-09-29T07:59:49+00:00,Neuropeptide,#E3F2FD,#1565C0,Brain,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
158,nad+,19.0,,,"NAD⁺ is an essential coenzyme present in all living cells, acting as an electron carrier in redox reactions critical for energy metabolism, DNA repair, and signaling pathways involving sirtuins and PARPs. It oscillates between its oxidized form (NAD⁺) and reduced form (NADH) to enable these functions.","NAD⁺ accepts electrons during metabolic reactions, becoming NADH, which then donates electrons in processes such as oxidative phosphorylation and anabolic pathways. NAD+ serves as a substrate for enzymes like sirtuins, PARPs, and cADP-ribose synthases, facilitating DNA repair and protein modifications. In the hypothalamus, NAD⁺ modulates feeding behavior by entering neurons via connexin 43, activating SIRT1/FOXO1 pathways to suppress hunger-driving neuropeptides. In ischemic heart tissue, NAD⁺ reduces apoptotic signaling and improves antioxidant capacity.",https://upload.wikimedia.org/wikipedia/commons/thumb/f/fe/NAD%2B.svg/250px-NAD%2B.svg.png,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl][(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",663.4 g/mol,"Cardiovascular Health, Neurological Health, Mitochondrial Function, Obesity, Performance",,C21H27N7O14P2,NAD+,2025-09-07T23:17:37+00:00,2025-09-27T16:46:41+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
159,zhenoluten,24.0,,"ZhENOLUTEN, Genoluten, Genaluten",Zhenoluten is a bioregulatory peptide complex derived from ovarian tissue of young animals. It belongs to a class of organ-specific peptide extracts and was first developed in the 1980s in Russia.,"Zhenoluten is believed to act as a regulatory signal, interacting with DNA promoter sequences to initiate protein synthesis in ovarian cells through RNA polymerase activation. Zhenoluten:  Normalizes cellular metabolism in ovarian tissue, promotes oocyte maturation, restore cyclic ovarian activity, supports hormonal regulation.",,,,"Fertility, Endocrinology, Hormonal Regulation",,,Zhenoluten,2025-09-09T16:12:02+00:00,2025-09-09T16:23:41+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
160,visoluten,24.0,,A‑11,Visoluten is a peptide bioregulator or more specifically A‑11 eye tissue peptide complex - extracted from the eye tissues of young animals. It was developed by researchers at the St. Petersburg Institute of Bioregulation and Gerontology,"Visoluten mechanism hinges on the idea of short signaling peptides acting as gene expression regulators. It binds to specific promoter regions in the DNA of corresponding tissue, causes local unwinding of the DNA helix and facilitates RNA polymerase binding and activation, thereby stimulating synthesis of proteins essential for tissue function and repair.",,,,"Ophthalmology, Neurology, Gerontology, Regenerative Therapy",,,Visoluten,2025-09-10T05:06:37+00:00,2025-09-10T05:18:56+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
161,vesselget,24.0,,"A-7 vascular peptide complex, Cytomax A-7",Vesselget is a peptide complex isolated from the vascular tissue of young calves. It is part of the Cytomax line of peptide bioregulators developed by the St. Petersburg Institute of Bioregulation and Gerontology.,"Vesselget translocates into the cell nucleus of endothelial and smooth muscle cells and there it interact with specific DNA sequences, modulating chromatin conformation, thereby activating transcription of vascular-specific genes. This regulation improves synthesis of structural and regulatory proteins necessary for vascular wall stability. Vesselget peptides enhance endothelial nitric oxide synthase expression - promoting vasodilation, reduce endothelial dysfunction - a key factor in hypertension and atherosclerosis, Normalize barrier function - reducing vascular permeability and inflammatory infiltration. Vesselget peptides help maintain epigenetic stability in vascular cells by supporting DNA repair and chromatin structure, modulating histone acetylation/methylation, regulating microRNAs linked to vascular inflammation and remodeling.",,,,"Cardiovascular Health, Epigenetics, Endothelial Dysfunction, Genetic Transcription","https://doi.org/10.1134/S2079057014040122, https://doi.org/10.1134/S2079057013030065, https://doi.org/10.1007/s10522-009-9249-8,  https://doi.org/10.3390/molecules26227053",,Vesselget,2025-09-11T16:25:14+00:00,2025-09-11T16:32:26+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
162,thymogen,24.0,Glu–Trp,"Glu–Trp dipeptide, sodium L-glutamyl-L-tryptophan","Thymogen is a synthetic dipeptide originally derived from thymus peptide extracts. It is considered a second-generation thymic immunomodulator, designed to reproduce the biological activity of natural thymic hormones in a defined, standardized form.","Thymogen penetrates lymphocyte nuclei and interacts with DNA regulatory regions. It upregulates transcription of genes related to T-cell receptor (TCR) synthesis and signal transduction pathways. It enhances mRNA stability for proteins involved in lymphocyte activation. Thymogen promotes differentiation of immature thymocytes into functional CD4+ and CD8+ T cells,
stimulates IL-2 receptor expression - enhancing responsiveness to interleukin-2, normalizes helper-to-suppressor T-cell ratios. Thymogen enhances antigen presentation by increasing MHC class II molecule expression on macrophages and dendritic cells, activates natural killer cells and cytotoxic T lymphocytes, improving antiviral and antitumor defense, regulates cytokine production to restore balanced immune responses. Thymogen supports DNA repair and chromatin structure in immune cells, thereby prolonging their functional lifespan.",https://www.peptidesciences.com/media/wysiwyg/Thymagen_Molecule.png,(2S)-2-(3-(1H-indol-3-yl)-2-(methylamino)-3-oxopropanoylamino)pentanedioic acid,349.34 g/mol,"Genetic Modulation, Immunology, Immune System","https://doi.org/10.1023/A:1021570110410, https://doi.org/10.1007/s10522-009-9249-8, https://doi.org/10.3390/molecules26227053, https://doi.org/10.1007/BF02833892",C16H19N3O6,Thymogen,2025-09-11T16:52:41+00:00,2025-09-11T17:45:48+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
163,taxorest,24.0,,"Bronchial peptide complex, bronchoprotector peptide",Taxorest is a peptide bioregulator complex developed from bronchial mucosa extracts. It belongs to the family of short peptides studied by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology.,"Taxorest peptides bind selectively to DNA in bronchial epithelial and immune cells and there it modulates mucosal repair proteins, antioxidant enzymes, cytokines. Taxorest promotes differentiation of progenitor cells into functional ciliated epithelial cells - improving airway clearance, enhances synthesis of glycoproteins and surfactant-related proteins - restoring normal mucus viscosity, stimulates fibroblast activity for balanced connective tissue turnover. It normalizes the ratio of Th1/Th2 lymphocytes, reducing allergic-type hyperreactivity, enhances macrophage phagocytosis and local antigen presentation and improves production of secretory IgA - strengthening mucosal barrier immunity. Taxorest also downregulates excessive NF-κB signaling and  lowers neutrophil recruitment and oxidative stress in bronchial mucosa.",,,,"COPD, Pulmonary decline, Asthma, Bronchitis","https://doi.org/10.1007/s10522-006-9016-1, https://doi.org/10.3390/molecules26227053,  https://doi.org/10.1023/A:1010083215625",,Taxorest,2025-09-11T17:25:06+00:00,2025-09-11T17:32:31+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
164,svetinorm,24.0,,"Liver peptide bioregulator A-7, Natural liver peptides, Peptide complex A-7",Svetinorm is a bioregulatory liver peptide complex derived from the liver tissue of young animals. It belongs to a class of organ-specific peptide extracts and was first developed in the 1980s in Russia.,"Svetinorm is believed to act as a regulatory signal, interacting with DNA promoter sequences to initiate protein synthesis in hepatocytes through RNA polymerase activation.
It normalizes cellular metabolism in liver tissue, promotes regeneration of hepatocytes, supports lipid metabolism, enhances detoxification processes, and contributes to restoration of liver function after damage.",,,,"Hepatology, Chronic Hepatitis, Intoxication Recovery, Lipid Metabolism Disorders, Digestive Health, Anti-aging Support",,,Svetinorm,2025-09-17T01:31:25+00:00,2025-09-17T01:36:50+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
165,ovagen,24.0,Glu‑Asp‑Leu,,"Ovagen is a synthetic tripeptide described to have effects particularly in the liver and gastrointestinal tract: modulating fibrosis, protecting mucosal layers, counteracting damage from antibiotics, toxins, chemotherapy.",Ovagen acts as a competitive inhibitor of the mature HIV‑1 protease enzyme. It is derived from a region of the Gag‑Pol polyprotein of HIV‑1.  Studies have shown Ovagen to have promise as a potential anti-aging peptide in the liver and GI tract. Research has shown that Ovagen can reduce fibrosis in the liver and protect the GI mucosal layer.,,(2S)‑2‑(4‑carboxy‑3‑oxobutanamido)‑4‑oxo‑4‑((2S)‑4‑methylpentanoylamino)butanoic acid,375.37 g/mol,"HIV, Immunology, Hepatology, Gastroenterology, Anti-Aging",,C15H25N3O8,Ovagen,2025-09-20T23:12:05+00:00,2025-09-20T23:23:17+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
166,stamakort,24.0,,Peptide Complex A‑10,"Stamakort is a bioregulator peptide complex derived from gastric mucosa of young, healthy animals.","Stamakort increases protein synthesis in gastric musocal cells, helps restore damaged mucosal lining and improves gastric function like acid and enzyme secretion.",,,,"Gastritis, Gastroduodenitis, Ulcers, Pancreatitis, Malnutrition, Digestive Dysfunction",,,Stamakort,2025-09-20T23:28:59+00:00,2025-09-20T23:32:55+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
167,pielotax,24.0,,peptide complex A‑9,"Pielotax is a peptide bioregulator developed by the Russian Scientific-Production Center of Revitalization and Health. It is derived from the renal parenchyma of young animals, specifically designed to support kidney function. The concept of peptide bioregulators was pioneered by Professor Vladimir Khavinson, who discovered that short peptides could selectively interact with DNA to regulate gene expression, thereby restoring cellular function and promoting tissue regeneration.","Pielotax selectively targets kidney cells. It binds to specific DNA sequences within the promoter regions of genes in kidney cells. This binding induces the unwinding of the DNA double helix, facilitating the activation of RNA polymerase and initiating gene transcription. The result is the upregulation of protein synthesis, which supports cellular repair, regeneration, and the restoration of normal metabolic functions within the kidneys.",,,,"Nephropathy, Kidney Stones, Renal Failure, Nephroptosis",,,Pielotax,2025-09-20T23:41:48+00:00,2025-09-20T23:42:12+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
168,gotratix,24.0,,"Muscle Peptide Bioregulator A‑18, peptide complex A‑18",Gotratix is a peptide complex produced by the St. Petersburg Institute of Bioregulation and Gerontology. It is a natural peptide extract from animal muscle tissue of young animals.,"Gotratix's peptide fractions are said to be information molecules that interact with promoter regions of certain genes, causing disjoining of DNA double helix strands and activation of RNA polymerase, thereby inducing protein synthesis. These peptides are claimed to have a selective effect on myocytes, normalizing metabolism in these cells, increasing their functional activity, and reducing muscle fatigue under physical stress. It is believed to regulate peroxidation processes in muscle tissues.",,,,"Performance Enhancement, Chronic Fatigue, Atrophy Prevention, Anti-Aging",,,Gotratix,2025-09-20T23:47:08+00:00,2025-09-20T23:52:24+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
169,glandokort,24.0,,peptide complex A‑17,Glandokort is a peptide complex produced by the St. Petersburg Institute of Bioregulation and Gerontology. It is a natural peptide extract derived from adrenal gland tissue of young animals.,"Glandokort's peptides normalize metabolism, promote protein synthesis in adrenal cells and help restore functional activity of the gland in conditions of stress or aging.",,,,"Fatigue, Adrenal Fatigue, Stress, Endocrinology",,,Glandokort,2025-09-20T23:56:26+00:00,2025-09-21T00:00:18+00:00,Bioregulator,#E0F2F1,#00796B,Dna,2025-08-06T20:14:24+00:00,2025-08-06T20:14:24+00:00
171,bacteriostatic-water,29.0,,"Sterile water, Bacteriostatic water for injection, Water for injection, Sterile water for injection","Bacteriostatic water is a sterile, non-pyrogenic water preparation containing 0.9% (9 mg/mL) benzyl alcohol as a preservative / bacteriostatic agent. Because of the benzyl alcohol, it is supplied in a multiple-dose vial from which repeated withdrawals may be made, provided aseptic technique is used. The pH is typically ~5.7.","The benzyl alcohol does not kill all bacteria outright but inhibits their growth and reproduction, in other words: holds potential contaminants in a static state, hence the name bacteriostatic. This allows repeated puncture of the vial without overt overgrowth of microbial contaminants. In microbiology terms, this is distinguished from bactericidal agents.",,,108.14 g/mol,"Injectable reconstitution, Injectable Dilution, Intranasal Dilution, Preservation",,,Bacteriostatic Water,2025-10-05T08:50:24+00:00,2025-10-05T09:24:31+00:00,Solvent,#E3F2FD,#1565C0,Beaker,2025-10-05T08:40:48+00:00,2025-10-05T08:41:06+00:00
172,acetic-acid,29.0,,"Ethylic acid, Vinegar acid, Ethoic acid, Ethanoic acid","Acetic acid, better known as the acid part of vinegar, is a weak organic acid, medically used as a solvent and antiseptic.","Acetic acid partially dissociates into acetate when dissolved in water, resulting in a lower pH environment without complete dissociation. This reduced pH inhibits the growth and survival of many bacteria, fungi, and biofilms. Acidic conditions can also disrupt calcium or mineral encrustations. When acetic acid enters microbial cells in its undissociated form, it releases H⁺ ions, which further lowers the cytoplasmic pH, denatures proteins, disrupts enzyme functions, and damages cell membranes, ultimately weakening or killing the microorganisms. Additionally, acetic acid demonstrates effectiveness against biofilms, which are notoriously difficult to eliminate. Research indicates that at moderate concentrations, acetic acid can reduce biofilm formation, while higher concentrations or prolonged exposure can eliminate established biofilms. In the realm of pharmaceutical manufacturing, acetic acid aids in solubilizing weakly basic drugs, enhancing their solubility.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=176&t=l,acetic acid,60.05 g/mol,"Wound care, Surgical Irrigation, Antiseptic, Urinary Tract Irrigation, Solvent, Dry Spray Production",,C2H4O2,Acetic Acid,2025-10-05T09:24:24+00:00,2025-10-05T09:38:06+00:00,Solvent,#E3F2FD,#1565C0,Beaker,2025-10-05T08:40:48+00:00,2025-10-05T08:41:06+00:00
173,hexarelin,19.0,His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2,"Examorelin, EP-23905, MF-6003","Hexarelin is a synthetic hexapeptide. It is part of the class of growth hormone releasing peptides derived from GHRP-6 analogs and acts as a growth hormone secretagogue. It is not structurally similar to the endogenous hormone ghrelin, but mimics some of ghrelin’s effects via the ghrelin receptor.","Hexarelin binds to the ghrelin receptor in the hypothalamus and pituitary, stimulating GH release. It can potentiate GH secretion beyond what GH-releasing hormone alone can do, and shows synergistic effects with GHRH in some settings. Some experiments suggest that hexarelin might also trigger an unknown hypothalamic factor in addition to direct and indirect effects in stimulating GH. It may also inhibit angiotensin converting enzyme.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=6918297&t=l,(2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(2-methyl-1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide,887.059 g/mol,"Growth Hormone Deficiency, Anabolism, Performance Enhancement, Regeneration, Fibrosis","https://www.sciencedirect.com/topics/neuroscience/hexarelin, https://academic.oup.com/ejendo/article-abstract/135/4/481/6755168?redirectedFrom=PDF&login=false, https://www.sciencedirect.com/science/article/pii/S0753332220303577",C47H58N12O6,Hexarelin,2025-10-05T09:56:00+00:00,2025-10-05T10:27:52+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
174,mgf,28.0,Tyr‑Gln‑Pro‑Pro‑Ser‑Thr‑Asn‑Lys‑Asn‑Thr‑Lys‑Ser‑Gln‑Arg‑Arg‑Lys‑Gly‑Ser‑Thr‑Phe‑Glu‑Glu‑Arg‑Lys–NH₂,"INSULIN-LIKE GROWTH FACTOR 1-EC PEPTIDE, IGF-1-EC, MECHANO GROWTH FACTOR","MGF is an alternatively spliced variant of insulin-like growth factor-I presenting a unique C-terminal modification. Due to this unique C-terminal, MGF is exceptionally good at stimulating muscle tissue stem cells and their activation.","After muscle damage or overload, your body produces IGF-1, which can be spliced into MGF. MGF stimulates satellite cell activation and muscle repair, essentially telling the muscle to grow and regenerate. Natural MGF acts locally and degrades quickly, but produces significant localized growth.",,IGF‑1 Ec splice variant peptide,2867–2888 g/mol,"Muscle growth, Muscle Recovery, Performance, Tendon repair","https://pubmed.ncbi.nlm.nih.gov/21354439/, https://pubmed.ncbi.nlm.nih.gov/27334712/",C121H200N42O39,MGF,2025-10-05T10:58:46+00:00,2025-10-05T11:05:43+00:00,Anabolic,#E3F2FD,#1565C0,Syringe,2025-09-07T21:23:32+00:00,2025-10-05T08:41:38+00:00
175,ptd-bdm,3.0,RRRRRRRRGGGGRKTGHQICKFRKC,"EX-A13483, Protein Transduction Domain-fused Dishevelled Binding Motif",PTD-DBM is a peptide developed from the group up by a research team at Yonsei university in South Korea with the intention of reversing and preventing hairloss. It's effects are enhanced by Wnt/β-catenin signaling activators like Valproic acid.,"PTD-DBM interferes with CXXC5 binding to Dishevelled which would otherwise cause negative feedback for Wnt/β-catenin pathway - a key regulator of cell proliferation and differentiation. This basically means that the Wnt/β-catenin mediated cell growth and proliferation is disinhibited by PTD-DPM. This is especially displayed in the hair as PTD-DBM can not only slow down hair loss but stimulate hair follicle development leading to regrowth. Wnt/β-catenin also stimulates insulin sensitivity in skeletal muscle cells. Lastly Wnt/β-catenin is incredibly relevant in neurology as it stimulaters neural stem cell proliferation, allowing for regeneration of nervous system cells.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=176453931&t=l,H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Gly-Gly-Gly-Gly-Arg-Lys-Thr-Gly-His-Gln-Ile-Cys-Lys-Phe-Arg-Lys-Cys-OH,3082.6 g/mol,"Hair Loss, Insulin Sensitivity, Neurogenesis, Anemia, Vascular Development","https://doi.org/10.1038%2Fcr.2008.47, https://doi.org/10.1371%2Fjournal.pone.0008509, https://doi.org/10.1182%2Fblood-2007-04-084186, https://doi.org/10.1016%2Fj.jid.2017.04.038, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493411, https://doi.org/10.1016%2Fj.jid.2017.04.038",C124H225N61O28S2,PTD-BDM,2025-10-07T10:50:41+00:00,2025-10-07T11:06:23+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
176,zinc-thymulin,3.0,H-Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH,"Zn-Thymulin, Zinc thymic factor, Zinc facteur thymique serique","Zn-Thymulin is a metallopeptide conjugate of Zinc and Thymulin. Thymulin is a peptide produced by the thymus in relation with the circadian rhythm. It has significant immune and neuroendocrine effects. Its analgesic, neuroprotective and anti-inflammatory. Its deficiency is associated with Anorexia Nervosa. Zinc deficiency can simulate and induce Thymulin deficiency and a big portion of Zinc deficiency symptoms can be explained by lack of Thymulin. Thymulin's effects are zinc dependant which is why it is conjugated into a metallopeptide with Zinc.","Thymulin induces intra and extra-thymic T cell differentiation, stimulates T helper cells, regulates cytotoxic T lymphocytes. Additionally it also regulates cytokines especially IL-2. It's anti-inflammatory effects are mediated by Treg activity, Nf-kB regulation, M2 macrophage polarization, NK cell enhancement and cytokinen modulation. Zn-Thymulin mediated localized zinc delivery, anti-inflammatory effects and its effects on T-cells promote transition into the anagen phase and hair proliferation.",https://muscleandbrawn.com/wp-content/uploads/2023/05/ZN-Thymulin.png,L-Pyroglutamyl-L-alanyl-L-lysyl-L-seryl-L-glutaminyl-glycyl-glycyl-L-seryl-L-asparagine,858.864 g/mol,,,C33H54N12O15,Zinc Thymulin,2025-10-07T11:33:03+00:00,2025-10-07T12:07:30+00:00,Regeneration,#E8F5E9,#2E7D32,Dna,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
178,methylene-blue,19.0,,"Methylthioninium chloride, Methylthionine Chloride, Swiss Blue, Basic Blue 9",Methylene blue (MB) is a synthetic heterocyclic aromatic chemical compound (a thiazine dye) first synthesized in 1876. It was one of the first synthetic drugs used in medicine and has diverse clinical and research applications.,"MB is a redox-active compound that can alternate between oxidized and reduced forms. This allows MB to act as an artificial electron carrier, shuttling electrons in cellular systems. MB accepts electrons from NADPH via NADPH-methemoglobin reductase, reducing methemoglobin into functional hemoglobin. MB bypasses majority of the electron transfer chain, carrying electrons over from Complex I straight to Cytochrome C which gives it to Complex IV. This reduces ROS production and stimulates Complex IV activity, enhancing ATP production and lower oxidative stress. At higher doses it acts as a Acetylcholinesterase inhibitor and a Reversible Monoamine Oxidase A Inhibitor. It also inhibits NOS and sGC which is relevant for some individuals.",https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=6099&t=l,[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium chloride,319.9 g/mol,"Neurodegenerative Diseases, AMPD1 Deficiency, Mitochondrial Disorders, Psychiatry, Cognitive Enhancement, Sepsis, Oxidative Stress, Anti-Aging",,C16H18ClN3S,Methylene Blue,2025-10-13T16:05:54+00:00,2025-10-13T16:16:24+00:00,Metabolic,#FFF8E1,#F9A825,Beaker,2025-04-15T02:28:26+00:00,2025-04-15T02:28:26+00:00
1006,testt,,,,,,,,,,,,testing,2025-11-08T22:12:47.701727+00:00,2025-11-08T22:12:47.701727+00:00,,,,,,
